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Le Bonheur est une bulle de savon qui change de couleur comme l’iris et 
qui éclate quand on la touché.  
       Balzac 	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Si vide d’espoir est le monde du dehors que deux fois plus précieux m’est 
le monde de dedans. 
       Emily Brontë 	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Fear was born in the very same moment as mankind. And since we will never be able to 
master it, we will have to learn to live with it – just as we have learned to live with storms. 
Therefore, although fear is a part of life, never let it control you. 
 
       Paulo Coelho 
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ABSTRACT 
The brain observes, detects, learns, and remembers signals coming from our external 
environment. In particular, it senses danger, and once detected, the related sensory 
signal, be it auditory, visual or somatosensory, triggers synaptic plasticity, enabling the 
brain to learn and remember the event. During Pavlovian fear conditioning, animals learn 
to associate a negative stimulus, such as a mild foot-shock, with a neutral stimulus, like a 
novel sound or context. This association leads to long-lasting changes in the animals’ 
behavior upon re-exposure to the neutral stimuli that, in rodent, is expressed by a 
“freezing” fear posture. Fortunately, these fear memories, in rodent and human, 
extinguish with repeated exposure to the neutral stimuli in absence of the negative 
stimulus. If fear extinction were impaired, however, one would live every day in an 
anxious state of exaggerated fear. Humans with post-traumatic stress disorder suffer from 
a persistent fear memory that is resistant to extinction. Although therapies based on 
extinction already exist, their efficiency is low and the majority of patients experience 
relapse.  
This thesis proposes that a detailed investigation of the molecular mechanisms underlying 
the synaptic plasticity of fear extinction will enable better treatment for anxiety disorders, 
and uses electrophysiology to step modestly in that direction.  
Fear memory formation and extinction occur principally in the amygdala, a brain area 
localized within the temporal lobe. The amygdala receives sensory stimuli primarily from 
the thalamus and cortex and long-term potentiation of thalamo- and cortico-amygdalar 
synaptic transmission is believed to underlie fear memory formation. In contrast, fear 
extinction is thought to involve long-term depression of these circuits.  
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My doctorate focused on understanding the molecular pathways underlying long-term 
depression of thalamo- and cortico-amygdalar projections.  
I found that thalamic and cortical inputs carry distinct molecular pathways, such as distinct 
receptors localized at different sites of long-term depression induction.  
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CHAPTER 1: GENERAL INTRODUCTION 
Fear 
Fear is an emotional state related to behavioral and physiological responses induced by a 
specific stimulus, such as pain or the threat of danger. Fear is the most highly conserved 
emotion that occurs throughout the animal kingdom1,2. It is a basic survival mechanism 
that allows an organism to either fight or escape (flight) from a danger1. However, in 
extreme cases of fear, such as horror and terror, fear might be maladaptive, 
unproductive, and even harmful3. An example illustrating a severe outcome of extreme 
fear, such as the consequences of exposure to a traumatic event, are human anxiety 
disorders4.  
Anxiety disorders, also known as fear-related disorders, are some of the most prevalent 
psychiatric illnesses, affecting about 15% of the population worldwide4. They include 
panic disorder, social anxiety disorder, specific phobias, obsessive-compulsive disorder, 
generalized anxiety disorder and post-traumatic stress disorder (PTSD)4-7.  
PTSD is by far the most studied5 of the anxiety disorders, as it is the only major mental 
disorder for which there is a clear understanding of its cause8. For example, PTSD can 
develop after exposure to any psychologically traumatic event, from combat exposure, 
natural disasters, domestic violence (during childhood or adulthood), life-threatening 
accidents8-10, and mobbing11.  
PTSD belongs to the family of anxiety disorders, because in most cases the stimulus that 
produced the initial fear response is no longer present as an active threat. A key symptom 
in patients with anxiety disorders is that they possess exaggerated fear reactions to 
situations that would in healthy humans be considered safe3. This is caused by an 
alteration of the process called fear extinction, meaning that the fear memory of the 
traumatic event is resistant to decay3,5,8.  
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A perturbation in fear extinction is the cause of some of the key symptoms of PTSD, 
including intrusive memories of the traumatic event, such as re-experiencing the event 
during flashbacks and nightmares3,8, avoidance of reminders of the traumatic event, 
hyper-arousal and emotional numbing3,8. These symptoms lead to sleep disorders, 
personality changes, cognitive impairments and destructive forms of self-medication9,10. It 
is therefore crucial to understand the mechanisms underlying learning and memory of 
fear, since this may lead to more efficient treatments for anxiety disorders, and for PTSD 
in particular. 
Fear conditioning 
Of the various models available to study fear learning and memory12, Pavlovian (or 
classical) fear conditioning is commonly considered a gold-standard in the field, since it 
has proven both successful and useful for understanding the underlying mechanisms of 
normal and pathological fear responses1,3,5,8. Pavlov based his behavioral paradigm on 
the universal concept of the fear-reflex: an aversive/fearful stimulus gives rise to a fear 
response13. Since all species have conserved a fear-reflex as a primary survival 
mechanism, Pavlovian fear conditioning can be applied on a multitude of different 
animals, from rodents to humans8,14-16. 
In rodents, classic fear conditioning consists of presenting the animal with an emotionally 
neutral conditioned stimulus (CS), such as a tone, associated with an aversive 
unconditioned stimulus (US), such as an electrical foot-shock. The foot-shock then elicits 
spontaneous unconditioned fear responses (UCRs), such as freezing or increased heart 
rate. After one or several CS-US pairings, the CS alone is able to elicit conditioned fear 
responses (CRs), suggesting that the rodent has learned that the CS is followed by the 
US, leading to the formation of an associative fear memory1,8. The commonly measured 
CR is related to defensive behaviors such as freezing.  
	   	  
	   	  	  	  	  
13	  
Freezing is a behavior observed in rodent species in their natural environment, and is 
thought to be a crucial fear response needed for survival in an environment where even 
small movements may attract predators’ attention. For example, in humans, encountering 
a snake in a field will initially evoke a freezing response, followed by flight (running away) 
or vocalization (screaming)17. Other types of CRs often analyzed include autonomic 
nervous system (ANS) responses, such as increased blood pressure and heart rate, 
neuroendocrine responses (the release of hormones from pituitary and adrenal glands), 
alterations in pain sensitivity (analgesia) and reflexes (fear-potentiated startle and eye 
blink responses)1,2,18.  
Normally the previously acquired conditioned fear memory progressively extinguishes 
over time after a persistent absence of the aversive signals (US). This phenomenon is 
known as the extinction of fear memory and can also be studied using Pavlovian fear 
conditioning. To illicit fear extinction, the CS (the tone) is repetitively applied in the 
absence of the US (electrical foot-shock). In this configuration, the CS alone will elicit a 
decrease in expression of the CRs, since the tested animal learns that the CS is no 
longer paired with the US, thereby leading to the extinction of the conditioned fear 
memory1,15,19.  
Pavlovian fear conditioning can also be applied to humans8,14,20,21. In humans, the CS is 
often based on the presentation of images or sounds related to the trauma the patient has 
been faced to in his past, the US is often mediated by an electric shock to the wrist or 
fingers, and the observed CRs are mainly the heart rate, startle effect or skin 
conductance5,7,8,14,20,22. Using these parameters, PTSD patients show an abnormal 
resistance to fear extinction with a normal fear memory compared to healthy patients3,5-
8,10,15,20,21,23.  
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Similar to humans with PTSD, rats that have been exposed to a traumatic event, such as 
a predator threat (placement of the rats on soiled cat litter for 10 min) before fear 
conditioning exhibit impaired fear extinction and a normal fear memory24.  
In summary, classical fear conditioning has been extensively investigated in rodents, and 
is increasingly applied on humans 20. The findings from rodents’ research have been 
supported and extended in humans, by using neuropsychological and neuroimaging 
methodologies 22. Research on fear conditioning helped to describe a brain circuitry 
thought to be responsible for the acquisition, expression and the extinction of fear 
memory. A goal of fear research is to understand how to treat the potentially destructive 
effects of anxiety disorders, such as PTSD, in humans. As an outcome, fear extinction 
has been identified as a key target for future potential treatment for anxiety disorders. 
Thus, understanding the brain anatomy involved in fear extinction is one crucial step 
towards a therapeutic application of PTSD research.  
The anatomy of fear extinction 
The identification of the principal brain structures involved in fear circuitry, as well as their 
functionality, has been possible due to the use of the fear-conditioning paradigm in 
combination with other techniques, such as electrophysiology, e.g. extracellular field and 
whole-cell patch clamp recordings, and neuroimaging studies, including functional 
magnetic resonance imaging (fMRI) and positron electron microscopy (PET). In rodents 
and humans, the three main brain areas involved in fear circuitry are the amygdala, the 
sensory thalamus and the sensory cortex.  
In fear conditioning, the auditory and somatosensory information emitted from the CS and 
US, respectively, are first received by the sensory thalamus. From the thalamus, the 
sensory information is forwarded either directly to the amygdala through the internal 
capsule (ic, Figure 1) or indirectly, via projections to the sensory cortical areas (auditory 
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cortex and somatosensory cortex for auditory and somatosensory information, 
respectively). The sensory cortex sends afferents to the amygdala via the external 
capsule (ec).  
The lateral nucleus of the amygdala (LA, see The amygdala) integrates the CS and US 
related information and projects to the central nucleus of the amygdala (CE), which is 
responsible for eliciting fear responses. For doing so, the CE afferents project to other 
brain regions, such as the hypothalamus (HYP) and the periaqueductal gray (PAG), 
leading to the release of hormones that control the blood pressure and induce freezing 
behavior1,2,25-30 (Figure 1).  
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Figure 1. The principal brain regions involved in the processing of fear conditioning.  
 
The sound emitted by the CS and the electrical foot pain induced by the US reach the 
auditory and somatosensory thalamic and cortical nuclei, respectively. The sensory thalamic 
input directly reaches the LA (blue arrow), whereas the cortical input to the LA is indirect 
since the sensory information passes first through the thalamus, which then projects to the 
sensory cortex (yellow arrows). The thalamic and cortical pathways send inputs through the 
internal and external capsule to the LA, from where the information is transmitted to the CE 
(red arrow) The CE outputs reach certain brain regions involved in eliciting fear responses 
(purple arrows), such as the PAG for freezing behavior, the autonomic nervous system 
(ANS) and the hypothalamus for releasing hormones responsible for fear reactions. The 
auditory pathway is better characterized than the somatosensory pathway (grey arrows). 
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THE AMYGDALA 
The amygdala is the main brain region responsible for fear processing, fear learning and 
the storage of fear memory1-3,5,7,8,15,19,21,23,25,26,31. The morphology of the amygdala, as 
well as its role in fear memory, has been highly conserved across evolution1,18,32,33.  
Brown and Schafer had hypothesized its involvement in the processing of fear responses 
as early as 1888 34. They observed that rhesus monkeys with a lesion in the temporal 
lobe that included the amygdala had social and emotional deficits 34. In 1939, Klüver and 
Bucy repeated Brown and Schafer’s experiments with better accuracy at targeting the 
amygdala, and showed that injured monkeys are hypo-emotional and do not manifest any 
fear upon aversive stimuli 35. Similarly, humans suffering from Urbach-Wiethe disease, a 
rare genetic disorder that often leads to bilateral amygdala abnormalities, do not exhibit 
any fear responses36 and have deficits in the recognition of fearful facial expressions37. 
Furthermore, electrical stimulation of the amygdala in humans results in autonomic 
reactions of fear or anxiety38. Additionally, in rodents, lesions of the amygdala prevent 
conditioning freezing8,17,26-28,30,39-43. Finally, selected rodents with a physiological deficit in 
fear extinction (physiological resistance to extinction of fear observed during classical fear 
conditioning paradigm) showed a dysfunction in amygdalar activity44. This abnormal 
amygdalar activity is also observed in humans suffering from PTSD, and is associated 
with an impaired fear extinction compared to healthy controls3.  
The amygdala belongs to the limbic system, an important area for emotional processing 
in both humans and rodents45. It is localized ventrolaterally in the temporal lobe, and is 
composed of several nuclei and subnuclei46.  
The most relevant nuclei of the amygdala related to fear are the lateral (LA), basolateral 
(BLA, which includes basal (B) and the accessory basal (AB)), and the central (CE) 
nuclei46 (Figure 2).  
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The LA is the first amygdalar nucleus that receives the CS inputs from the auditory 
thalamus and auditory cortex26. Therefore, this nucleus is of crucial relevance in the 
processing of fear. Moreover, specific damage to the LA disrupts fear memory47. The LA 
integrates auditory information from thalamic and cortical inputs and forwards the sensory 
information via direct or indirect (via BLA) outputs to the CE (Figure 2). The CE then 
projects to the brain stem and the hypothalamus (HYP) for eliciting conditioned fear 
responses (CRs)39.  Projections from the CE to the periaqueductal gray (PAG) lead to 
freezing and hypoalgesia, while projections to the lateral hypothalamus are involved in the 
control of conditioned cardiovascular responses1,39 (Figure 1). 
THE SENSORY THALAMUS 
The thalamus is the principal relay center for processing information to the cortex48.  
Indeed, all sensory information, except for olfaction, is transmitted through the thalamus 
before reaching the cerebral cortex49. The neural activity within the thalamic nuclei is 
involved in attention and arousal50. Interestingly, both attention and arousal are clearly 
reduced in PTSD patients3,51. In fact, a common feature observed in PTSD is thalamic 
dysfunction, which can be detected by neuroimaging studies51-55. It has even been shown 
that this thalamic dysfunction may be the underlying mechanism responsible for 
flashbacks (intrusive memories of the traumatic event) in PTSD55.  
In rodents, lesions of the auditory thalamic nuclei interfere with fear conditioning56. 
Retrograde labeling from the LA identified the specific nuclei involved in the transmission 
of the auditory CS28,30.  
These nuclei are those that receive afferents from the inferior colliculus, an obligatory 
relay center in the ascending auditory system. These nuclei are the ventral, the dorsal, 
and the medial part of the medial geniculate body (MGB, including MGv, MGd, and 
MGm), as well as areas of the posterior thalamus, including posterior intralaminar nuclei 
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(PIN)26-28,30,56. The thalamo-LA projection consists of a direct transmission from auditory 
processing regions in the thalamus, mostly from the MGm/PIN to the LA (Figure 2). 
THE SENSORY CORTEX 
The sensory cortex plays an important role in hierarchizing the sensory processing, which 
starts with the primary sensory areas and continues in unimodal and multimodal 
association areas, as well as the prefrontal cortex51. These higher order sensory areas 
are involved in the integration of information coming from the primary sensory cortex and 
have a role in coordinating aspects of multimodal somatosensory-visual-auditory 
integration51. The greater neural activity in the amygdala observed by fMRI upon 
presentation of the CS in PTSD compared to healthy humans correlates with enhanced 
activity in the anterior cingulate cortex (ACC) and orbitofrontal cortex of the sensory 
cortex5,57. The activities of these cortices are interconnected and are mainly involved in 
decision-making58,59, socially-driven interactions60, and empathy-related responses61, all 
of which are disrupted in PTSD8-10,51,62.  
In rodents, lesions and tracing studies led to identification of the main sensory cortical 
areas involved in the circuit of fear27,63-66. The nuclei of the sensory cortex involved in 
auditory fear conditioning are the primary auditory cortex (TE1), the secondary auditory 
cortex (TE2, TE3) and the perirhinal cortex (PRh) (Figure 2).  
While the thalamo-LA projection consists of a direct transmission from auditory 
processing regions in the thalamus to the amygdala, the cortico-LA projection is an 
indirect transmission arising first from the auditory thalamic nuclei (MGv, MGd and 
MGm/PIN) to the TE1, followed by TE1 to TE2/TE3, and finally from TE2/TE3 to PRh, 
ending eventually in the LA28. Thus, within the thalamic nuclei, the MGv and MGd nuclei 
project to LA exclusively via cortical relays, while the MGm/PIN nucleus projects both 
directly and indirectly to the LA1 (Figure 2). 
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Figure 2. The auditory pathways involved in fear. 
 
A, a schema of an adult rodent brain showing the CS-auditory pathways activated upon a tone 
emission. B, two coronal slices (taken from http://www.mbl.org) representing two sections 
(bregma -2.92 and 1.64 respectively) from posterior to more anterior (dashed grey lines in A). 
The CS-related information reaches the auditory thalamus via the inferior colliculus. The 
thalamus sends direct input (blue arrows) to the LA through the internal capsule (ic). The 
thalamic nuclei responsible for direct transmissions to the LA are the MGm and PIN (Down, 
left coronal brain slice). The cortico-LA connection is an indirect transmission from thalamic 
nuclei such as MGd and MGv (Yellow arrows). The primary auditory cortex, TE1, after 
receiving thalamic projections, forwards the sensory information to the secondary auditory 
cortical areas (TE2 and TE3) and the PRh, which finally project afferents to the LA through the 
external capsule (ec). The LA integrates the CS-related information and gives the information 
to the CE either directly or indirectly (red arrows) via the BLA. The CE is responsible for fear 
responses by activating several brain regions such as the HYP and the PAG (purple arrows). 
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THALAMIC AND CORTICAL INPUTS TO THE LA 
As described above, the thalamic and cortical afferents send convergent but temporally 
separated inputs to the LA26,27, with the thalamic input to the LA arriving about 12 ms 
faster than the cortical input27,28. Humeau and colleagues (2005) found that these 
convergent inputs reach a single cell in the LA by targeting the same dendrite but 
contacting neighboring and morphologically distinct types of spines67. Larger spines are 
contacted by thalamic afferents whereas smaller spines are contacted by cortical 
afferents67. This suggests that each pathway may carry different sensory information to 
the LA neurons67,68. Nevertheless, both inputs to the LA are sufficient to support fear 
conditioning as well as fear extinction27, although by different mechanisms. For example, 
the direct inputs from the auditory thalamus to the LA seem to have a larger processing 
capacity in auditory fear conditioning elicited by a simple (classical) auditory CS than 
cortical inputs27,68. On the other hand, the indirect afferents from the auditory cortex to the 
LA contribute more to the processing of a complex CS69-71, for example, in a differential 
(and non-classical) fear conditioning paradigm. In the differential fear conditioning 
paradigm, the tested animal must discriminate between a CS paired with an US and an 
unpaired CS alone (which does not result in a negative expectation)69-71.  
In summary, the fear-related emotional inputs arrive first to the LA by the direct thalamic 
pathway as a rapid but coarse warning signal, whereas the indirect cortical pathway to the 
LA provides a slower but more accurate representation of the same emotional stimulus. 
The cortical information can thus confirm the first and fast warning signal from the 
thalamus, thereby giving rise to CRs if the stimulus represents a real threat1,45.  
The transmission of the CS-related information from both afferents to the LA is induced by 
the ability of these inputs to change the strength of synaptic transmission during fear 
memory and its extinction.  
	   	  
	   	  	  	  	  
23	  
The ability of the synapses to change in strength between two neurons in response to 
sensory signals, such as for example those elicited by the CS, is known as synaptic 
plasticity. Synaptic plasticity is believed to be the basis of information storage in the brain.  
As thalamic and cortical afferents are thought to carry distinct but convergent sensory 
information to the LA neurons, it is plausible to hypothesize that their ability to change the 
synaptic strength at LA synapses may be different as well. Therefore, studying synaptic 
plasticity in the LA, especially during fear extinction, may result in novel understandings of 
how to ameliorate this behavioral deficit in PTSD. 
Synaptic plasticity in the LA 
The two most widely studied forms of synaptic plasticity are long-term potentiation (LTP) 
and long-term depression (LTD)72,73.  LTP is characterized by a persistent long-lasting 
enhancement of synaptic strength, whereas LTD is defined as a long-lasting reduction in 
synaptic strength73,74. Following the acquisition of fear memory, both inputs to the LA 
show an enhanced synaptic transmission. On the other hand, previously enhanced 
transmission at both thalamo- and cortico- LA synapses is reversed during extinction of 
fear75-78. Therefore, thalamic and cortical projections undergo opposite changes in 
synaptic strength during fear conditioning and fear extinction75,76,79-86.  
Extensive studies have shown that long-lasting enhancement in synaptic transmission, 
such as those occurring in LTP at both thalamo- and cortico-LA synapses, may be the 
underlying mechanism mediating associative memory of the CS-US association during 
auditory fear conditioning78,82,83,85,87,88.  
On the other hand, LTD is thought to be the synaptic mechanism of fear extinction, since 
a long-lasting depression was observed at both thalamic and cortical inputs to the LA 
during fear extinction75,76. Additionally, in vivo LTD induction after fear conditioning 
performed either in rats89 or primates90 gives rise to fear extinction. Given that a defect in 
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fear extinction is thought to contribute to PTSD, studying the molecular mechanisms 
underlying LTD associated with fear extinction is of vital importance to the development of 
future treatments for PTSD74.  
MOLECULAR MECHANISMS UNDERLYING LTD IN THE LA 
Both thalamic and cortical synaptic connections to the pyramidal LA neurons are 
glutamatergic28,91,92, meaning that they use glutamate as the main neurotransmitter. 
Furthermore, the thalamo- and cortico-LA synapses are asymmetric92, which is often 
associated with excitatory neurotransmission93,94. Moreover, both thalamic and cortical 
inputs to pyramidal LA neurons contain glutamatergic receptors, such as the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and N-methyl-D-aspartate 
receptor (NMDAR)95-98. These two receptors are crucial for NMDAR-dependent synaptic 
plasticity, the main form of plasticity in the brain99,100. In fact, NMDAR-dependent LTD is 
the most common type of LTD within the central nervous system74. For example, 
perfusion of D-APV, a strong and potent NMDAR antagonist, abolishes LTD in many 
different brain regions74. In the LA, NMDAR inhibition abolishes both LTD74,101-104 and fear 
extinction74,105,106. Additionally, NMDAR-dependent LTD is occluded at thalamo- and 
cortico-LA synapses in slices from extinction-trained rats75,76. Thus, a strong link between 
NMDAR-dependent LTD and extinction has been demonstrated. However, the molecular 
mechanisms underlying NMDAR-dependent LTD in the LA at both thalamic and cortical 
inputs remain poorly understood.  
Since pharmacologically blocking NMDAR activity blocks LTD as well as fear extinction, 
drug therapies aimed at activating NMDARs, by injection of D-cycloserin (DCS), a partial 
NMDAR-agonist, in patients suffering from PTSD is commonly used as a treatment in 
association with extinction-based psychotherapy training (see discussion, 8,20,107). 
However to date, this type of pharmacotherapy has a very low success rate due to side 
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effects, such as epilepsy and memory loss. This may be caused by the ubiquitous need 
for NMDARs either in LTP or in LTD and other types of plasticity. Therefore, a promising 
approach for improving these pharmacotherapies in PTSD would be to investigate the 
downstream molecular pathways underlying the regulation of the NMDARs at both inputs 
to the LA. This may help to decrease the side effects after therapy, since both LTP and 
LTD require distinct downstream regulative pathways but share NMDAR requirements.  
THE NMDA RECEPTORS IN LTD 
NMDARs are ionotropic transmembrane receptors for glutamate, and known to be the 
most important trigger for synaptic plasticity100. They are ligand- and voltage- dependent, 
as they are activated mostly by the removal of the Mg2+ blockade upon depolarization, 
and require glycine and glutamate binding for channel opening108. Once the ion channel is 
open, the NMDAR enables Na+ and Ca2+ ions to enter, and K+ to exit the cell109, thereby 
leading to activation of Ca2+- dependent intracellular signaling pathways. It is thought that 
a strong depolarization gives rise to a high postsynaptic Ca2+ influx, which leads to LTP, 
whereas a weak depolarization gives rise to a low or moderate postsynaptic Ca2+ influx, 
which results in LTD74,110. Additionally, the Ca2+-mediated intracellular signaling pathways 
downstream of the NMDARs can recruit different molecular targets depending on the 
NMDAR subunit composition109.  
In the brain, the NMDARs are mostly constituted of two NR1 subunits associated with two 
NR2 subunits, where NR1 contains the glycine sites and NR2 gathers glutamate, thus 
conferring the electrophysiological properties of the receptor108,109,111-113. Among the four 
NR2 subunits (NR2A-NR2D), NR2A and NR2B are the most extensively studied, due to 
their broad expression in the brain112, and because they have been shown to have 
important roles in synaptic plasticity108,109,114,115. For example, in cortical layers, in the 
CA1 of the hippocampus and at thalamo-LA synapses of the amygdala, NR2A-containing 
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NMDARs are required for LTP induction, whereas the induction of LTD recruits 
specifically NR2B-containing NMDARs114-117.  
Although less studied due to lack of specific and efficient antibodies, NR2C and NR2D 
subunits seem to play a more important role in LTD compared to LTP, as demonstrated in 
the hippocampal CA1 subregion118.  
It is thought that thalamic and cortical pathways carry distinct sensory information to the 
LA, and the difference between these inputs is hypothesized to be due to divergence in 
their NR2 subunit specificity99,119. However, whether NMDAR-dependent LTD recruits 
distinct types of NR2 subunits-containing NMDARs at both thalamic and cortical inputs to 
the LA remains unclear120,121. This is relevant to explore since the distinct types of NR2 
subunits composing the receptor may also attribute a difference in synaptic 
localization99,119. For example, the NR2C/D-containing NMDARs may be activated even in 
the absence of depolarization or only by glutamate binding119 due to their 
electrophysiological properties. Thus, they are mostly present at the presynaptic 
compartment of a neuron122, in contrast to NR2A/B-containing NMDARs, which are 
mostly postsynaptically expressed and require both depolarization and glutamate 
binding100,108,109,112,119,123-125. Indeed, in the neocortex, presynaptic NR2C/D-containing 
NMDARs are believed to be involved in presynaptic LTD126,127, and at thalamo-LA 
synapses NR2B subunits are exclusively expressed postsynaptically123.  
However, NR2C/D-containing NMDARs have never been explored in the amygdalar LTD. 
A difference in NR2 subunits and in the synaptic localization of the NMDARs may prove 
that both afferents carry distinct CS-related sensory information to the LA due to their 
distinct NR2 subunits. 
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Therefore, further investigation of the contribution of distinct NR2 subunits during LTD at 
both afferents to the LA will provide insight into whether and how these pathways are 
differentially regulated during LTD and thus fear extinction.  
THE REGULATION OF THE NMDAR-DEPENDENT LTD  
NMDAR-dependent LTD is mainly regulated by post-translational modifications, such as 
dephosphorylation, by signaling molecules regulating synaptic transmission128-139. 
Protein-phosphatase 1 (PP1), a member of the serine (Ser) and threonine (Thr) family of 
protein phosphatases (PPs), is one of the most highly conserved proteins in eukaryotic 
cells129,130,140-142, and is responsible for regulating a variety of cellular processes143-145. 
The role of PP1 has mostly been analyzed in the hippocampus, where it regulates 
learning and memory139 through its action on RNA splicing146, gene transcription134,135, 
apoptosis147, and synaptic transmission148-150. Specifically, modulation of PP1 activity 
influences the directionality of synaptic plasticity. Whereas PP1 inhibition is required for 
LTP151-153, PP1 activation leads to LTD148-150,153.  
Amongst the PP family members, PP1, PP2A, PP2B (also known as calcineurin), PP4, 
PP5, PP6 and PP7 are expressed in mammalian neurons. In particular, PP1, PP2A and 
PP2B account for the majority of Ser and Thr PP activity in vivo143-145. Together, they 
dephosphorylate more than 90% of the neuronal phosphate-bound proteins154.  
Due to its ubiquitous localization and its function in regulating a broad range of cellular 
functions, PP1 is the best characterized of the PPs142.  
Thus, when low frequency stimulation (LFS) is applied to CA3-CA1 Schaeffer collaterals 
of the hippocampus, the influx of Ca2+ entering through the NMDARs into the 
postsynaptic CA1 neurons binds to calmodulin (CaM), leading to the activation of a 
protein-phosphatase (PP) cascade.  
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Once activated, the calcium/calmodulin-dependent PP2B dephosphorylates inhibitor-1 
(I1, a specific inhibitor of PP1), thereby releasing PP1 from I1 inhibition149,150 (Figure 3).  
Once PP1 is active, it is brought to the vicinity of the NMDARs found in the postsynaptic 
density (PSD), by scaffolding proteins148,155,156. Its role during LTD consists of 
dephosphorylating various targets74 involved in synaptic plasticity, including AMPAR155-157 
and NMDAR124,158. The regulation of AMPAR and NMDAR plays a crucial role in 
hippocampal LTD74,100,159. For example, the PP1-mediated dephosphorylation of a 
specific serine residue on the AMPAR during LTD is responsible for receptor 
internalization and is known to enable LTD expression103,125,155-157,159. On the other hand, 
whether PP1 dephosphorylates NMDARs during LTD is still unclear. In the hippocampus, 
the NMDARs showed decreased activity during NMDAR-dependent LTD158. It is 
hypothesized that PP1 is responsible for this change in NMDARs activity158 (Figure 3).  
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Figure 3. The role of PP1 in hippocampal post-synaptic NMDAR-dependent LTD.  
 
A, in the basal state, the synaptic transmission is mediated by the flux of sodium (Na2+) 
into the cell and the flux of potassium (K+) out from the internal compartment of the neuron 
through the AMPAR. This creates a excitatory post-synaptic current (EPSC) changing the 
membrane potential (EPSP). PP1 is not active in basal synaptic transmission, since I1 
inhibits its activity. PP2B is Ca2+- dependent and therefore at basal synaptic transmission, 
PP2B is inactive, since there is no calcium (Ca2+) influx into the cell through NMDAR. The 
NMDAR is not open yet because of the Mg2+ blockade. I1 is activated upon 
phosphorylation mediated by PKA. PKA, I1, PP2B and PP1 are gathered by A-kinase 
anchoring protein (AKAP). B, upon LFS, NMDAR activation triggers a low influx of Ca2+ 
into the postsynaptic neuronal compartment. The activation of the NMDAR leads to the 
transport of PP2B and PP1 by anchoring proteins such as AKAP, which binds PP1, PP2B 
and PKA. The calmodulin (CaM) detects Ca2+ and leads to the activation of the Ca2+- 
dependent PP2B. Once activated, PP2B dephosphorylates I1, releasing PP1 blockade 
and leading to its activation. C, amongst the various targets that PP1 can 
dephosphorylate, the GluR1 subunit of the AMPAR at its Ser845 is of crucial importance 
for NMDAR-dependent LTD, since its dephosphorylation leads to the internalization of the 
receptor. PP1 is also able to act on the NMDAR by an unknown mechanism leading to the 
down-regulation of the receptor.  The drawings of the cell membranes and the receptors 
have been taken from http://www.servier.com/Powerpoint-image-bank. 
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As a key regulator of NMDAR-dependent LTD in the hippocampus, PP1 has been shown 
to play a crucial role in cognitive functions. In fact, activation of PP1 limits hippocampus-
dependent learning and memory and promotes forgetting139, whereas PP1 inhibition 
enhances learning and memory133,139. Notably, LTP impairment is rescued by PP1 
inhibition in a mouse model of Alzheimer’s disease137. In addition, our lab recently 
demonstrated that the role of PP1 might extend beyond the hippocampus to include the 
amygdala133, where an enhanced fear memory upon genetic PP1 inhibition has been 
associated with an improved LTP at cortico-LA synapses133.  
Given that PP1 is essential to LTD in the hippocampus, and that LTD is the synaptic 
correlate of fear extinction in the amygdala, it is plausible to hypothesize that PP1 may 
regulate fear extinction through modulating LTD in the amygdala. If this were true, it 
would be possible that a novel treatment for PTSD could involve enhancing LTD by 
increasing PP1 activity in the amygdala of individuals by facilitating fear extinction. 
However, the role of PP1 in amygdalar LTD remains unexplored. Below, an overview of 
the current knowledge related to LTD at thalamic and cortical inputs to the LA is provided. 
LTD AT THE THALAMIC PATHWAY 
At the thalamic fibers to the LA, LTD is input-specific and postsynaptic101. Its induction is 
most likely mediated by postsynaptic NR2B-containing NMDARs114,121, and NR2B 
activation leads to endocytosis of AMPARs for LTD expression103,125. This process is 
made possible by inhibition of protein kinase Mζ (PKMζ), which is known to be essential 
for the formation of long-term memories by blocking endocytosis of AMPARs160. 
Interestingly, blocking NR2B-containing NMDARs as well as blocking endocytosis of 
AMPARs impairs the extinction, but not the expression, of conditioned fear114,161. 
Additionally, LTD induced at thalamic inputs to the LA in brain slices harvested from fear 
conditioned rats depends on NR2B-containing NMDARs76,162 and correlates with a 
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decrease in AMPARs localized to synaptosomes in the LA76. This suggests that 
depotentiation and LTD may share the same molecular mechanisms at thalamo-LA 
synapses74. In addition, LTD involves mitogen activated protein kinase (MAPK) 
signaling163, which is likely activated upon Ca2+ influx through L-type voltage dependent 
calcium channels (L-VDCCs) located postsynaptically164. Similar to NR2B-containing 
NMDARs, L-VDCCs are thought to be required specifically for fear extinction165.  
Furthermore, LTD not only involves NMDARs, but also the group I metabotropic 
glutamate receptors (mGluRs) for their induction76, as well as an unspecified PP signaling 
cascade101. Indeed, non-specific blockade of PP2A/PP1 in the LA by perfusion of okaidic 
acid or calyculin A abolishes LTD at the thalamic pathway101. The existence of PPs at 
thalamo-LA synapses is consistent with a hypothetical role for PPs in endocytosis of 
AMPARs at thalamo-LA synapses, possibly triggered by activation of NMDARs103,125. 
However, whether and how PP1 is specifically required for thalamo-LA LTD is still 
unknown (Figure 4).  
LTD AT THE CORTICAL PATHWAY 
Since LFS is unable to induce LTD at cortical naïve synapses, most of the 
electrophysiological work performed at cortico-LA synapses makes use of depotentiation 
for studying cortical LTD. In this configuration, LFS succeeded in inducing LTD after LTP 
induction. This form of LTD, which is thought to share common downstream molecular 
pathways with de novo LTD, also depends on NMDARs75,102, but surprisingly does not 
lead to AMPAR endocytosis75. In addition, cortico-LA LTD not only depends on NMDARs 
but also requires the activation of group II mGluRs75.  
This suggests LTD expression occurs presynaptically, since 1) group II mGluRs are 
mainly localized at the presynapses, at least in the hippocampal mossy fibers-CA3166,167 
and at the nucleus accumbens synapses168, and 2) the internalization of AMPARs, which 
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are exclusively postsynaptic, is not required75. However, group II mGluRs can occur both 
pre- and post-synaptically in several brain regions such as in the hippocampus and 
cortex169. Thus, whether cortical LTD is pre- or post-synaptic remains to be determined by 
additional experiments, for example by chelating postsynaptic Ca2+, or specifically 
blocking activated postsynaptic NMDARs before LTD induction. LTD at the cortical 
pathway is also thought to recruit the NR2B subunit121. This finding remains controversial, 
because distinct NMDAR subtypes are believed to be expressed at thalamic and cortical 
inputs when electrophysiological analyses were performed at basal synaptic transmission 
(no synaptic plasticity)120. Furthermore, electrically induced depotentiation in vivo reduces 
fear conditioning-mediated phosphorylation of MAPK and protein kinase B (PKB), which 
is correlated with increased activity of PP2B, and PP2B inhibition blocks fear extinction 
and MAPK dephosphorylation102,170 (Figure 4). As PP2B seems to be involved in cortico-
LA depotentiation, PP1 may also play a role in this pathway during LTD. However, this 
potential role remains unexplored. 
In summary, a shared feature of thalamo- and cortico- LA LTD is that they both require 
NMDARs. Despite the crucial role LTD plays in extinction of fear memory, the molecular 
mechanisms underlying LTD in the LA remains poorly explored. The focus of my thesis 
was to further identify the molecular mechanisms underlying LTD at both thalamic and 
cortical inputs to the LA, with a special focus on PP1 and the NMDAR subunits. The main 
questions explored in the presented experiments were 1) whether PP1 is required during 
NMDAR-dependent LTD, 2) which NR2 subunits are responsible for PP1 downstream 
activity, and 3) whether the site of LTD expression at both inputs to the LA is pre- or 
postsynaptic.  The answers to these questions may provide new and crucial insights into 
how a potential treatment for anxiety disorders, such as PTSD, could be developed by 
targeting LTD-related signaling during extinction. 
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Figure 4. The current knowledge of the molecular mechanisms underlying LTD at thalamic 
(left) and cortical (right) inputs to the LA neurons.  
 
A, LTD at the thalamic inputs to the LA neurons is purely postsynaptic, requires NR2B-
dependent NMDARs, which once activated trigger AMPAR endocytosis. L-VDCCs and 
group I mGluRs are also involved in LTD at thalamic afferents, both localized 
postsynaptically, where in collaboration with the NMDARs, they contribute to the 
postsynaptic rise of Ca2+, leading to a downstream MAPKs signaling pathway. However, the 
postsynaptic PP2B/PP1 signaling cascade upon a rise of postsynaptic Ca2+ has not been 
elucidated yet. B, LTD at the cortical afferents is still poorly known. It implicates NMDARs 
and group II mGluRs. The subunit-specificity of the NMDARs at the cortical inputs needs to 
be confirmed, since it is still a debated topic. NMDARs activation leads also at these 
synapses to a downstream MAPKs signaling pathway. It has been suggested that LTD at 
the cortico-LA synapses depends on presynaptic mechanisms, since group II mGluRs are 
mostly localized at the presynapses. However in the hippocampal DG as well as other 
cortical areas, postsynaptic group II mGluRs are involved in LTD. Therefore the site of LTD 
at cortico-LA synapses remains unresolved. PP2B is needed in cortico-LA LTD, however it 
is still unknown whether PP1 is required.  
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CHAPTER 2: MAIN PROJECT 
This chapter has been published to Frontiers in molecular neuroscience: 
Mirante O, Brandalise F, Bohacek J, Mansuy I M (2014). Distinct molecular components for 
thalamic- and cortical-dependent plasticity in the lateral amygdala. Frontiers in Molecular 
Neuroscience, 3 (7): 62. 
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Abstract 
N-methyl-D-aspartate receptor (NMDAR)-dependent long-term depression (LTD) in the 
lateral nucleus of the amygdala (LA) is a form of synaptic plasticity thought to be a cellular 
substrate for the extinction of fear memory. The LA receives converging inputs from the 
sensory thalamus and neocortex that are weakened following fear extinction. Combining 
field and patch-clamp electrophysiological recordings in mice, we show that a paired-
pulse low-frequency stimulation can induce a robust LTD at thalamic and cortical inputs to 
LA, and we identify different underlying molecular components at these pathways. We 
show that while LTD depends on NMDARs and activation of the protein phosphatases 
PP2B and PP1 at both pathways, it requires NR2B-containing NMDARs at the thalamic 
pathway, but NR2C/D-containing NMDARs at the cortical pathway. LTD appears to be 
induced postsynaptically at the thalamic input but presynaptically at the cortical input, 
since postsynaptic calcium chelation and NMDAR blockade prevent thalamic but not 
cortical LTD. These results highlight distinct molecular features of LTD in LA that may be 
relevant for traumatic memory and its erasure, and for pathologies such as post-traumatic 
stress disorder (PTSD).  
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Introduction 
Synaptic plasticity, a property of neuronal connections characterized by a change in 
synaptic strength following neuron activation, is essential for memory formation but also 
for forgetting. Whether presynaptic stimulation increases or decreases synaptic strength 
depends on the magnitude of postsynaptic calcium elevation 171. Long-term potentiation 
(LTP), a form of synaptic strengthening, is induced by a high rise in intracellular calcium 
concentration leading to activation of protein kinases. In contrast, long-term depression 
(LTD), a form of synaptic weakening, requires a moderate rise of intracellular calcium 
concentration that activates protein phosphatases including PP2B (calcineurin) and PP1 
149,150,153,172,173.  
In the lateral amygdala (LA), LTP is associated with the formation of fear memory 82,83,88, 
while LTD is thought to underlie the extinction of fear memory 75,76,162. Molecular 
manipulations that interfere with fear extinction do indeed impair LTD 102,114,161,174,175. The 
LA is a complex limbic structure that integrates sensory information from cortical and 
thalamic afferents. These afferents are highly plastic 21,176 and converge onto single 
neurons in LA 67. To date, LTD in LA has been mostly studied at the thalamic pathway, 
essentially because it is easier to induce than at the cortical pathway 101,164,177. Similar to 
fear extinction 105,106,114,178, LTP at the thalamic pathway depends on NMDARs and is 
primarily associated with the NR2B subunit 104,106,114,121,125. In contrast, the mechanisms of 
LTD at the cortical pathway remain unknown, but are postulated to be different from those 
at the thalamic pathway 179,180. We investigated these mechanisms in adult mouse LA and 
examined whether they involve the phosphatases PP2B and PP1, and which NMDAR 
subunits they recruit. Here we show that both PP2B and PP1 are involved in LTD in the 
amygdala, but that distinct NMDAR subunits are implicated at thalamic and cortical 
pathways.  
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While LTD depends on NR2B-containing NMDARs at the thalamic pathway, it requires 
NR2C/D-containing NMDARs at the cortical pathway. We also show that LTD is induced 
postsynaptically at the thalamic pathway, but not at the cortical pathway. 
Results 
PATHWAY-SPECIFIC LTD IN LA 
Using extracellular field recording, we first assessed whether a paired-pulse low 
frequency stimulation protocol (ppLFS) induces stable and input-specific LTD at thalamic 
and cortical afferents to the LA in slices from adult mouse (for electrode placement see 
Figure 1A). A robust LTD that lasted over 1hr was specifically induced at the pathway 
receiving ppLFS but not at a control pathway, both at thalamic (ppLFS pathway: 53.3 ± 
4.3%, n = 18 vs. control pathway: 106.2 ± 10.9%, n = 11, p < 0.001, Figure 1B) and 
cortical input (ppLFS pathway: 52.7 ± 3.6%, n = 18 vs. control pathway: 108.6 ± 12.2%, n 
= 14, p < 0.001, Figure 1B). The magnitude of fEPSP suppression was comparable 
between thalamic and cortical ppLFS (p > 0.9). These results indicate that the ppLFS 
protocol leads to a strong and input-specific induction of LTD (LA-LTD) at both thalamic 
and cortical pathways to LA.   
NMDAR-DEPENDENT LTD IN LA DEPENDS ON PROTEIN PHOSPHATASES 
In the hippocampus, the most common form of LTD requires postsynaptic rise in calcium 
that depends on NMDARs, and is associated with activation of a PP2B/PP1 signaling 
cascade 74. Both PP2B and PP1 are known to be negative regulators of plasticity that 
further, can act as memory suppressors 139,181,182. We thus first tested whether LA-LTD is 
NMDAR-dependent at both pathways using extracellular field recordings. LTD was fully 
blocked by the NMDAR antagonist D-APV (50 µM) at both, the thalamic (control: 50.6 ± 
5.6%, n = 6; D-APV: 103.0 ± 10.4%, n = 9, p < 0.001, Figure 1C) and cortical (control: 
53.7 ± 2.9%, n = 5; D-APV:  114.8 ± 9.9%, n = 9, p < 0.001, Figure 1C) pathway, 
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demonstrating that LA-LTD depends on NMDARs at both pathways. Input/output (I/O) 
curves were not affected by D-APV, suggesting that basal synaptic transmission was not 
altered (Figure 1C, insets).  
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Figure 1. Input-specific NMDAR-dependent LTD at the thalamic and cortical pathways in the lateral 
amygdala.  
(A) Schematic illustration of electrode placement for ppLFS and control pathway recording of the thalamic 
pathway (left) and the cortical pathway (right). (B) Robust, long-lasting LTD was specifically induced at the 
pathway receiving ppLFS (thalamic, n = 18; cortical, n = 18) but not at the control pathway (thalamic: n = 
11; cortical: n = 14). Insets show representative traces of extracellular field potentials averaged across 10 
mins before ppLFS (black line) and the last 10 minutes of recording after ppLFS (grey line). (C) D-APV (50 
µM) prevents LTD at thalamic afferents (control: n = 6; D-APV: n = 9) and (E) at cortical afferents (control: n 
= 5; D-APV: n = 9). Insets show I/O curves on top and below representative traces of extracellular field 
potentials averaged across 10 mins before ppLFS (black line) and the last 10 minutes of recording after 
ppLFS (grey line). Data represent mean ± SEM. *** = p < 0.001. 
 
 
 
-10 0 10 20 30 40 50 60 70 80
0
50
100
150
Time (min)
fE
P
S
P
s 
sl
op
e 
(%
 b
as
el
in
e)
Control
D-APV (50 µM)
D-APV
ppLFS
***
Control D-APV
5 ms
0.2 mV
Thalamic
0 50 100 150 200
0.0
0.1
0.2
0.3
0.4
Stim. Intensity
fE
P
S
P
s 
sl
op
e 
(m
V
 / 
S
ec
)
-10 0 10 20 30 40 50 60 70 80
0
50
100
150
Time (min)
fE
P
S
P
s 
sl
op
e 
(%
 b
as
el
in
e)
Control 
D-APV (50 µM)
D-APV
ppLFS
***
Control D-APV
5 ms
0.2 mV
Cortical
0 50 100 150 200
0.0
0.1
0.2
0.3
0.4
Stim. Intensity
fE
P
S
P
s 
sl
op
e 
(m
V
 / 
S
ec
)
C 
	   	  
	   	  	  	  	  
42	  
Next, we examined whether PP2B and PP1 are involved in LA-LTD. Perfusion of the 
selective PP2B inhibitor FK-506 (100 µM) abolished LTD at both, thalamic (control: 54.9 ± 
1.9%, n = 5; FK-506: 102.4 ± 10.9%, n = 5, p < 0.01, Figure 2A) and cortical (control: 48.3 
± 2.5%, n = 5; FK-506: 96.0 ± 5.0%, n = 5, p < 0.001, Figure 2A) pathways. Similarly, bath 
application of the specific PP1 inhibitor tautomycetin (4 nM) abolished LA-LTD at both 
pathways (Thalamic, control: 57.5 ± 5.2%, n = 5; tautomycetin: 101.4 ± 5.9%, n = 10, p < 
0.001. Cortical, control: 52.4 ± 6.7%, n = 7; tautomycetin: 118.2 ± 20.8%, n = 8, p < 0.05, 
Figure 2B). I/O curves were not affected by FK-506 (Figure 2A, insets) or tautomycetin 
(Figure 2B, insets), suggesting that basal synaptic transmission was not altered. These 
results show that LA-LTD requires PP2B and PP1 at both thalamic and cortical pathways. 
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Figure 2. PP2B and PP1 involvement in LTD at the thalamic and cortical pathways in the lateral amygdala.  
(A) The PP2B antagonist FK-506 (100 µM) blocks LTD induced at thalamic afferents (left panel, control: n = 
5; FK-506: n = 5) and at cortical afferents (right panel, control: n = 5; FK-506: n = 5). (B) The PP1 
antagonist tautomycetin (4nM) blocks LTD induced at thalamic afferents (control: n = 5; tautomycetin: n = 
10), and at cortical afferents (control: n = 7; tautomycetin: n = 8). Insets show I/O curves on top and below 
representative traces of extracellular field potentials averaged across 10 mins before ppLFS (black line) and 
the last 10 minutes of recording after ppLFS (grey line). Data represent mean ± SEM. *** = p < 0.001, ** = p 
< 0.001, * = p < 0.05.  	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LA-LTD DEPENDS ON ACTIVATION OF DIFFERENT NR2 SUBUNITS AT THALAMIC AND CORTICAL 
AFFERENTS 
We next investigated the NMDAR subunit composition implicated in LA-LTD at both 
inputs. While NR2A-containing receptors have previously been suggested to be involved 
in LTP in different brain structures, NR2B-containing receptors are thought to be involved 
in LTD 114,116,117,183,184, particularly in LA-LTD at the thalamic input 114,125. At the cortical 
pathway, however, the NMDAR subunit composition is still unclear 120,121. To test whether 
NR2B is required for LTD at both pathways, we used the selective NR2B antagonists 
ifenprodil (10 µM) and Co101244 (1 µM). While both antagonists fully blocked LTD at the 
thalamic pathway (control: 54.7 ± 5.7%, n = 5; ifenprodil: 118.0 ± 16.0%, n = 8; 
Co101244: 98.0 ± 10.5%, n = 5, p < 0.05 in both cases, Figure 3), they had no effect on 
LTD at the cortical pathway (control: 55.2 ± 5.9%, n = 5; ifenprodil: 48.2 ± 5.2%, n = 6; 
Co101244: 52.5 ± 12.2%, n = 5, p > 0.8, Figure 3). Ifenprodil and Co101244 did not affect 
I/O curves, suggesting no effect on basal synaptic transmission (Figure 3A, insets). These 
results demonstrate that LTD at the thalamic pathway is NR2B-dependent, while LTD at 
the cortical pathway is not. 
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Figure 3. LA-LTD at thalamic inputs specifically depends on NR2B-containing NMDARs.  
(A) Ifenprodil (10 µM) and Co101244 (1 µM) block LTD at thalamic afferents (left panel, control: n = 5; 
ifenprodil: n = 8; Co101244: n = 5) but not at cortical afferents (right panel, control: n = 5; ifenprodil: n = 6; 
Co101244: n = 5). (B) Summary of the average fEPSP slope over the last 20 min of recording after ppLFS. 
Insets show I/O curves on top and below representative traces of extracellular field potentials averaged 
across 10 mins before ppLFS (black line) and the last 10 minutes of recording after ppLFS (grey line). Data 
represent mean ± SEM. * = p < 0.05, ns = non significant.   
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To determine which other NR2 subunits may be implicated in LTD at the cortical pathway, 
we next tested the contribution of NR2C/D subunits (NR2A was previously reported not to 
be involved in LA-LTD 114). We used PPDA, a potent and dose-dependent selective 
NR2C/D antagonist 118,185. We used PPDA at low concentration (0.25 µM) to preferentially 
antagonize NR2C/D subunits, and at high concentration (1 µM) to antagonize all NR2 
subunits 185. At 0.25 µM, PPDA fully blocked LA-LTD specifically at the cortical input, but 
had no effect at the thalamic pathway (Figure 4). In contrast, 1 µM of PPDA abolished LA-
LTD at both pathways (thalamic, control: 45.2 ± 8.5%, n = 7; PPDA 0.25 µM: 44.3 ± 9.1%, 
n = 5; PPDA 1 µM: 113.6 ± 20.6%, n = 6, p < 0.01. Cortical, control: 41.6 ± 9.8%, n = 6; 
PPDA 0.25 µM: 113.3 ± 14.1%, n = 6, PPDA 1 µM: 107.1 ± 22.2%, n = 6, p < 0.05, Figure 
4). I/O curves were not affected by PPDA at either concentration (Figure 4A, insets).  
Overall, these results indicate that LTD at the thalamic pathway depends on NR2B-
containing NMDARs, whereas LTD at the cortical pathway depends on NR2C/D-
containing NMDARs. 
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Figure 4. LA-LTD at thalamic inputs specifically depends on NR2C/D-containing NMDARs.  
(A) PPDA does not affect LTD at the thalamic pathway at the NR2C/D-selective low dose of 0.25 µM, but 
blocks LTD at the non-selective high dose of 1 µM (left panel, control: n = 7; PPDA low dose: n = 5; PPDA 
high dose: n = 6). PPDA fully blocks LTD and at cortical pathway at both doses (right panel, control: n = 6; 
PPDA low dose: n = 6; PPDA high dose: n = 6). (B) Summary of the average fEPSP slope over the last 20 
min of recording after ppLFS. Insets show I/O curves on top and below representative traces of extracellular 
field potentials averaged across 10 mins before ppLFS (black line) and the last 10 minutes of recording 
after ppLFS (grey line). Data represent the mean ± SEM ** = p < 0.01, * = p < 0.05, ns = non significant. 
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DISTINCT LOCI OF LTD INDUCTION AT THALAMIC AND CORTICAL PATHWAYS 
Although LTD is generally thought to be induced postsynaptically, it is known that 
NMDAR-dependent LTD can also occur presynaptically in several brain regions 
126,127,186,187. NR2B-containing NMDARs are mostly localized postsynaptically 123,125,188,189 
and NR2C/D-containing NMDARs are mostly presynaptic 122,189,190 and have been 
implicated in presynaptic LTD in the somatosensory cortex 184. Because NR2B and 
NR2C/D subunits are differentially involved in LTD at thalamic and cortical pathways, we 
hypothesized that LTD may have different loci of induction at thalamic and cortical 
pathways. We tested this hypothesis using whole-cell patch clamp recording in LA 
pyramidal neurons. The recorded cells (n = 32) showed a firing pattern and spike 
frequency adaptation characteristic of LA pyramidal neurons (Figure 5 A, 94,120). The 
average resting potential of these neurons was -67.6 ± 4.3 mV. We observed a mono-
exponential relationship between current transients and voltage steps, indicating that 
excitatory cells in LA behave as single electrical compartments (t1 = 40.65 ± 0.1 ms). 
Transients were also used to estimate series resistance (15.3 ± 4.23 MΩ), input 
resistance (235 ± 42.47 MΩ) and membrane capacitance (67.7 ± 16.8 pF), all typical 
values for LA excitatory cells 94,120. 
Before assessing the locus of LTD induction, we examined whether LTD can be induced 
in individual excitatory LA neurons with the ppLFS protocol in current clamp configuration, 
and whether it depends on NMDARs. ppLFS induced a robust and persistent LTD in LA 
neurons, which was similar at thalamic and cortical inputs (thalamic: 47.38 ± 9.74%, n = 
4; cortical: 56.2 ± 4.6% n = 5, p > 0.3, Figure 5B). LTD was blocked by D-APV, confirming 
that it is NMDAR-dependent (thalamic: D-APV: 112.5 ± 3.0%, n = 3, p < 0.001; cortical: D-
APV:  108.1 ± 6.2%, n = 3, p < 0.01, Figure 5B).  
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Figure 5. NMDAR-dependent LTD in single pyramidal cells.  
(A) On top, response of a LA cell to current injection of -0.10 and +0.15 nA and below, hyperpolarizing 
voltage steps of 10 mV from a holding potential of -60 mV were used to measure series resistance. (B) D-
APV (50 µM) blocks LA-LTD induced at the thalamic pathway (left panel, control: n = 4; D-APV: n = 3), and 
at the cortical pathway (right panel, control: n = 5; D-APV: n = 3). Insets show the average of 10 sweeps of 
a single cell recorded 10 min before (black) and 30 min after (gray) ppLFS. 
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Because postsynaptic plasticity depends on changes in postsynaptic intracellular calcium 
concentration, we examined whether LTD is postsynaptic by preventing calcium increase 
at the postsynaptic site using the membrane impermeable calcium chelator BAPTA (100 
mM, dialyzed for 20 min before ppLFS). LTD at the thalamic pathway was fully blocked by 
BAPTA (control: 47.6 ± 6.7%, n = 4; BAPTA: 98.9 ± 5.7%, n = 4, p < 0.01) but it was not 
affected at the cortical pathway (control: 52.0 ± 6.6%, n = 5, BAPTA: 46.9 ± 6.1%, n = 5, p 
> 0.5, Figure 6A). These results suggest that the induction of LTD requires a postsynaptic 
rise in calcium at thalamo-LA synapses but not at cortico-LA synapses. To further assess 
the synaptic locus of LTD at thalamic and cortical synapses, we selectively blocked 
postsynaptic NMDARs before LTD induction by intracellular dialysis of the activity-
dependent NMDAR antagonist MK-801 (40 µM) into the pyramidal-like LA neuron. I 
n the presence of MK-801, LTD was fully blocked at thalamo-LA synapses (control: 37.9 ± 
13.5%, n = 3, MK-801: 104.3 ± 5.4%, n = 3, p < 0.05) but was not affected at cortico-LA 
synapses (control: 52.5 ± 14.2%, n = 3, MK-801: 54.8 ± 11.6%, n = 3, p > 0.9, Figure 6B), 
suggesting that LTD requires the activation of postsynaptic NMDARs at thalamic but not 
cortical synapses. Together, these results support a postsynaptic locus of LA-LTD at the 
thalamic pathway that likely depends on postsynaptic NMDARs, but a mechanism 
independent of postsynaptic NMDARs and independent of changes in postsynaptic 
calcium at the cortical pathway. 
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Figure 6. Distinct locus of LTD induction at thalamic and cortical pathways.  
(A) Dialysis of BAPTA blocks LA-LTD induced at the thalamic pathway (left panel, control: n = 4; BAPTA: n 
=4), but not at the cortical pathway (right panel, control: n = 5; BAPTA: n = 5). Insets show averaged traces 
of 10 sweeps taken 10 min before (black) and 30 min after (gray) ppLFS. (B) Dialysis of MK-801 (40 µM) 
blocks LA-LTD induced at the thalamic pathway (left panel, control: n = 3; MK-801: n = 3), but not at the 
cortical pathway (right panel, control: n = 3; MK-801: n = 3). Insets show averaged traces of 10 sweeps 
taken 10 min before (black) and 30 min after (gray) ppLFS. Data represent mean ± SEM. *** = p < 0.001. ** 
= p < 0.01, * = p < 0.05. 
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Discussion 
The protein phosphatases PP2B and PP1 are key players in the regulation of synaptic 
strength, and in the formation and the maintenance of memory traces 191-193. Activation of 
PP2B/PP1 signaling is known to be necessary for LTD in different brain regions 
148,150,174,194,195. This study provides novel evidence that these phosphatases are also 
involved in the induction of LTD in LA at both thalamic and cortical pathways.  This finding 
is in line with previous results showing that depotentiation at the cortical pathway in LA 
requires PP2B 102, and that PP2B and PP1 play an important role in memory tasks that 
depend on the amygdala including conditioned taste aversion and extinction of fear 
memory 133,174,196,197.  They also complement findings in the hippocampus that PP2B or 
PP1 inhibition enhances hippocampal LTP and memory performance in hippocampus-
dependent tasks 139,181 but impairs LTD 153. Taken together, these findings support the 
concept that PP2B/PP1 are key regulators of synaptic plasticity, and that their inhibition 
favors LTP and memory acquisition, but impairs LTD and memory extinction in both 
hippocampus and amygdala.   
The pathways involving PP2B/PP1 in LTD are currently best understood in the 
hippocampus, in particular at Schaffer collaterals between CA3 and CA1 pyramidal 
neurons. NMDAR-dependent LTD in CA1 neurons results from a low increase in 
postsynaptic intracellular calcium concentration 74 leading to PP2B activation, followed by 
dephosphorylation of the PP1 inhibitor-1 and subsequent PP1 activation 73,136,149,150,198. 
Once activated, PP1 dephosphorylates some of its targets in synaptic terminals 148, in 
particular, postsynaptic NMDAR and AMPAR subunits, leading to NMDAR 
downregulation and AMPAR endocytosis, ultimately resulting in synaptic depression (for 
review, see 193). Similar mechanisms may be engaged in the amygdala and would need 
to be investigated. 
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Our finding that LTD at the thalamic LA pathway is NR2B-dependent is consistent with 
previous studies 114,121,162. NR2B is present in postsynaptic densities (PSD) in LA 123, and 
LTD at the thalamic pathway depends on NR2B-dependent postsynaptic AMPARs 
endocytosis 125. Surprisingly, we observed that LTD induced at the cortical pathway is 
independent of NR2B signaling, since NR2B antagonists do not block LTD induction. 
Instead, we observed that blocking NR2C/D subunits fully prevents LTD at the cortical 
pathway, but does not affect LTD at the thalamic pathway. The observation that LTD at 
the cortical pathway is NR2B-independent contrasts with a previous report showing that 
antagonizing NR2B blocks LTD at both pathways in horizontal slices from adult mice 121. 
This apparent discrepancy likely results from a different orientation of the slices leading to 
different sites of stimulation and recording. Specifically, placing the stimulating electrode 
laterally to the internal capsule in coronal slices primarily activates cortical afferents to LA, 
but in horizontal slices, it also activates afferents from the entorhinal and perirhinal cortex 
121,199. The spatial organization of excitatory and inhibitory connections within the LA 
depends as well on slice orientation 200,201. It thus needs to be determined whether LTD 
differentially relies on NR2B or NR2C/D-containing receptors in the cortical pathway 
depending on the slice orientation. Given our clear finding that thalamic and cortical input 
to LA rely on different molecular and postsynaptic mechanisms, we postulate that 
projections to LA from the perirhinal and entorhinal cortex likely engage different 
mechanisms as well. Notably, most electrophysiological studies in the amygdala are 
conducted in coronal sections rather than horizontal sections 75,88,101,114,180,202. To our 
knowledge, this is the first report showing in coronal slices, a strong and reproducible 
induction of LTD at cortical afferents to LA by low-frequency stimulation, without the need 
of prior potentiation 75.  
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As highlighted by Müller et al (2009), this demonstrates that previous lack of LTD at 
cortical afferents 21,164 may be due to inadequate protocols for that specific pathway rather 
than an intrinsic failure to decrease synaptic transmission at cortical inputs to the LA. The 
availability of a robust LTD induction protocol at both input pathways to the amygdala in 
coronal slices shall allow further analyses of the mechanisms of LTD regulation in the 
amygdala. 
Our observation that different NR2 subunits mediate the effects of ppLFS-induced LTD at 
both input pathways to the LA are in agreement with previous studies reporting 
differences in the molecular cascades at these pathways in LTP and depotentiation 
67,75,180,203,204. Although the distribution of NMDAR subunits in the amygdala remains 
largely unknown, the receptor kinetics at resting membrane potential is known to be 
different at cortical and thalamic pathways 120. NMDARs at cortical inputs are less 
sensitive to magnesium blockade than at thalamic inputs, and the kinetic properties are 
akin to NR2C/D-containing NMDARs at the cortical pathway, but resemble NR2A/B-
containing NMDARs at the thalamic pathway 108,120,205. This is in agreement with our 
observation that NR2C/D-containing receptors seem to mediate LTD at the cortical 
pathway, but not at the thalamic pathway. 
Presynaptic NR2C/D-containing NMDARs are believed to be involved in spike-timing 
dependent LTD in the cortex 184. This prompted us to investigate the site of LTD induction 
at both LA pathways by whole cell patch-clamp recording. We observed that LTD 
induction occurs postsynaptically at the thalamic pathway, but is independent of 
postsynaptic calcium influx or postsynaptic NMDARs at the cortical pathway. These 
findings for LTD complement previous reports for LTP in the amygdala showing that LTP 
engages different pre- and postsynaptic mechanisms at thalamic and cortical pathways 
67,180,202,206-209.  
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Although distinct NMDAR subunits and postsynaptic mechanisms are involved at thalamic 
and cortical afferents to the LA, both pathways converge onto a PP2B/PP1 signaling 
cascade. In the hippocampus, calcium influx through NMDARs, rather than other calcium 
channels, is specifically required for PP2B and PP1 activation 210. It is possible that 
presynaptic calcium influx through NR2C/D-containing NMDARs, and postsynaptic 
calcium influx through NR2B-containing NMDARs, lead to the activation of PP2B/PP1 at 
the cortical and thalamic pathway, respectively, a possibility that will need to be tested in 
future experiments. Whether NR2C or NR2D subunits are localized presynaptically at 
cortical but not at thalamic afferents to LA will also need to be determined, as well as the 
molecular mechanisms downstream of PP2B/PP1 activation at both pathways. In the 
hippocampus, PP2B and PP1 have presynaptic and postsynaptic targets 191,211,212. In 
hippocampal and cortical neurons, PP1 can dephosphorylate NR2B 124,131, resulting in a 
downregulation of NMDAR activity 131.  Similarly, in cerebellar granule cells, PP2B 
downregulates NR2C expression 213, thus it is possible that PP2B/PP1 dephosphorylate 
NR2B and NR2C subunits differentially in LA in response to LTD induction. Finally, the 
contribution of other receptors such as metabotropic glutamate receptors (mGluRs) in LA 
LTD cannot be excluded. Group I mGluRs have previously been shown to contribute to 
ppLFS-induced depotentiation at the thalamic pathway 76, while presynaptic group II 
mGluRs seem to be involved at cortical afferents 75. Although mGluR-dependent LTD 
appears to involve tyrosine phosphatases rather than serine/threonine phosphatases 
such as PP2B and PP1 74,170, they may also contribute to the differential molecular effects 
of ppLFS-induced LTD at both pathways.  
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LA-LTD is associated with the extinction of fear memory 75,76,162. Since weakening and 
erasure of traumatic memory traces is critical for the management of anxiety disorders 
including PTSD 5,8,214-216, understanding the molecular mechanisms of LTD in the 
amygdala has important clinical implications. Our findings highlight the potential of 
therapeutically targeting PP2B/PP1 signaling to facilitate fear extinction learning in 
anxiety-related disorders 133,197,217. 
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Material and Methods 
Animals 
For all experiments, adult male mice C57Bl/6 (8-12 weeks old) were used. Animals were 
housed in standard housing conditions in a temperature- and humidity-controlled facility 
on a 12h reversed light/dark cycle. Mice had free access to food and water. All 
procedures were carried out in accordance with the guidelines of the Veterinary Office of 
the Canton of Zurich, Switzerland, and approved by its Commission for Animal Research 
(License numbers 150/2006 and 105/2008). 
Slices preparation 
Mice were anesthetized with isoflurane 99.9% (AttaneTM) and rapidly decapitated. 
Immediately after decapitation, the brain was extracted and sectioned in coronal slices 
(400 µm thick for extracellular field recordings, 300µm for whole-cell patch clamp 
recordings) in ice-cold modified artificial cerebrospinal fluid (aCSF) containing 175 mM 
sucrose, 20 mM NaCl, 3.5 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 1.3 mM 
MgCl2, and 11 mM D-(+)-glucose, and gassed with 95% O2/5% CO2 using a vibratome 
(VT 1000S; Leica Microsystems, Bannockburn, IL). Coronal slices were placed in a 
holding chamber at 34°C and incubated in normal aCSF containing 119 mM NaCl, 2.5 
mM KCl, 1.3 mM NaH2PO4, 26 mM NaHCO3, 1.3 mM MgCl2, 2.5 mM CaCl2, and 11 
mM D-(+)-glucose, and continuously bubbled with 95% O2/5% CO2 at 34°C for at least 
2.5 h, prior to recording. For recording, slices were transferred to a superfusion (1.5–2.5 
ml/min flow rate) chamber (Warner Instruments) heated at 33.5-34°C and held below a 
platinum wire. 
Electrophysiology 
The recording electrode was placed in the dorsal part of the LA, and the stimulation 
electrodes were placed close to the internal capsule and externally to the capsule to 
stimulate fibers originating from the thalamus or auditory cortex, respectively (see Figure 
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1A). Extracellular field excitatory postsynaptic potentials (fEPSPs) were recorded from the 
dorsal part of the LA, while basal single-electrical stimuli at 0.05 Hz were applied at both 
pathways. After 10 min of stable baseline fEPSPs recording, paired pulse low-frequency 
stimulation (ppLFS, 900 pulses at 1Hz, interstimuli interval (ITI) of 40 msec) was used to 
induce LTD 121. To test input specificity, ppLFS was induced at only one pathway (ppLFS 
pathway) whereas the other pathway was used as control and was stimulated with 0.05 
Hz baseline stimulation. fEPSPs were recorded using a glass pipette (2-4 MΩ of 
resistance) filled with normal aCSF. An input/output (I/O) response curve was established 
by varying the intensity of single-pulse stimulation. The stimulus intensity that evoked a 
fEPSP equal to 50 % of the maximum response was used for all stimulations. fEPSPs 
were amplified (Multiclamp 700B), filtered (low-pass filter 1 kHz, high-pass filter 1 Hz) and 
digitized at 10 kHz (Axoclamp 10.2). Whole-cell recordings were performed in a blind 
approach 218. The patch pipette (4-8 MΩ resistance) was filled with a solution containing 
(in mM): potassium gluconate 126, NaCl 4, MgSO4 1, BAPTA-free 0.1, BAPTA-Ca2+ 
0.05, glucose 15, ATP 3, HEPES 5 (pH was adjusted to 7.2 with KOH) and GTP 0.1. 
Membrane potential was measured relative to an agar-bridge reference electrode. 
Reported membrane potential values were adjusted off-line for liquid-junction potentials 
(usually < 5 mV). Voltage-clamp mode was used to record evoked excitatory postsynaptic 
currents (eEPSCs) from thalamic and cortical pathways. After stable baseline recording 
for at least 10 min, ppLFS stimulation was delivered in current-clamp configuration.  
Before and after ppLFS, series resistance was monitored by measuring the passive 
current transients induced by 10 mV hyperpolarizing voltage steps from a holding 
potential of -60 mV. Accepted deviations from this parameter in current transients 
recorded over the time-windows used for statistical analysis were less than 10% 219. Data 
were recorded using an Axopatch 200B amplifier, sampled with a Digidata-1440 interface 
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(sampling time = 250 msec for current-clamp recording, 10 msec for voltage-clamp 
recordings) and analyzed with P-CLAMP software (Axon Instruments, Foster City, CA) 
and Origin software (Microcal Software, Northhampton, MA). 
Drug application 
All drugs were bath applied at the indicated concentration starting at least 45 min before 
ppLFS and throughout recording, except D-(-)-2-Amino-5-phosphonopentanoic acid (D-
APV, 50 µM, Tocris), which was perfused for 10 min, starting 5 min prior to ppLFS 
delivery. The block specific NMDAR subunits, the NR2B antagonists ifenprodil 
hemitartrate (10 µM, Tocris) and Co101244 (1 µM, Tocris) were used, and the NR2C/D- 
antagonist [±]-cis-1-[phenanthren-2yl-carbonyl]piperazine-2,3-dicarboxylic acid (PPDA, 
Tocris, 0.25 µM to preferentially block NR2C/D-containing receptors and 1 µM to block 
NR2 subunits nonspecifically). FK-506 (100 µM, Tocris) and tautomycetin (4 nM, Tocris) 
were used to antagonize PP2B and PP1 activity, respectively 173,220. The calcium chelator 
1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA, 100 mM, Tocris) and 
the NMDAR open-channel blocker MK-801 (Dizocilpine, 40 mM, Tocris) were dialysed in 
individual postsynaptic LA neurons for >10 min through the patch pipette. To specifically 
and fully block activated NMDARs during MK-801 dialysis, cells were progressively 
depolarized from the holding potential of -70 mV to +30 mV, while thalamic or cortical 
pathways were stimulated about 200-300 times to allow irreversible binding of MK-801 to 
activated postsynaptic NMDARs 180,221. Consequently, the postsynaptic NMDAR 
component of EPSC activity was reduced after MK801 dialysis (charge transfer reduced 
by 28.6 ± 9.5% n = 3 for the thalamic pathway, and 17.2 ± 6.7% n = 3 for the cortical 
pathway). Cells were clamped again at -70 mV for another 10 min showing no significant 
change in the peak amplitude of AMPAR-mediated responses. 
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Data analysis 
Data analysis was performed using Clampfit software (v10.2, Molecular Devices, 
Sunnyvale, DA), GraphPad Prism (GraphPad Software Inc., San Diego, CA), and Excel 
(Microsoft). For all recordings, fEPSP slope, and EPSP and EPSC amplitude were 
normalized to the average of baseline slope and amplitude, respectively. To improve the 
signal-to-noise ratio, data were averaged into 1 min bins. For each experiment, two to 
three slices per animal were recorded, one was always used as control slice and one or 
two slices received drug-treatment. For statistical analyses, individual animals (not slices) 
were considered biological replicates. For both extracellular field and whole-cell 
recordings, data are expressed as mean +/- SEM. Statistical comparisons were 
performed using Student’s unpaired t-tests when two groups were compared. One-way 
ANOVAs were used when more than two groups were compared. If significant, ANOVAs 
were followed using Duncan’s post-hoc test. Significance was set to p < 0.05. 
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CHAPTER 3: GENERAL DISCUSSION 
PP1 as a potential therapeutic tool for PTSD 
Non-pharmacological treatment for PTSD and other anxiety disorders consists mostly of 
extinction-exposure therapy, which aims at facilitating fear extinction14,222. In this 
treatment, the patient is repeatedly presented with the CS in the absence of US or is 
required to talk about the general state of anxiety while simultaneously remembering the 
trauma or associated nightmares14-16. However, although this therapy can improve some 
symptoms of PTSD, in the majority of patients, extinction is not enhanced or patients 
relapse after their treatments with the mere passage of time (spontaneous recovery), 
changes of context (renewal) and the presentation of the US with which the CS has been 
initially paired (reinstatement) 15.  
Distinct behavioral manipulations have been tested as well, such as performing fear 
extinction during reconsolidation of fear memory 80,215,223. Reconsolidation is a process 
where other information or experience can be integrated to a memory trace, intended to 
modify retrieved memory by a process that integrates updated experience into long-term 
memory. Evidence suggests that this process destabilizes previously consolidated 
memory80,215,223. During reconsolidation, the synapses are thought to still be labile and 
therefore amenable to manipulation. By repeating fear extinction while the synapses are 
in this labile state, Monfils and colleagues showed a stronger and faster fear extinction 
than fear extinction alone (not performed during reconsolidation) 215. This experimental 
approach prevented the post-extinction return of fear. However, these results were not 
reproduced in several subsequent studies, performed in both rodents and humans 14,15.  
The relapse effect endures even when the extinction-based therapy is combined with 
pharmacological interventions, such as antidepressants or NMDARs agonists (for 
example, d-cycloserine, DCS) 15. The persistence of post-extinction relapse clearly 
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suggests that extinction-exposure therapy is not sufficient to erase the originally acquired 
fear memory. Thus, novel interventions with the potential to erase the CS-US association 
acquired during fear memory formation are needed.  One promising strategy would be to 
focus on the molecular mechanisms underlying LTD, since LTP, acquired in fear memory, 
is erased during fear extinction by LTD at both thalamo- and cortico- LA synapses 75-78.  
The major component of the molecular mechanisms underlying LTD is the PP2B/PP1 
signaling cascade downstream of NMDAR activation149,150. By dephosphorylating many 
targets including AMPARs and NMDARs, PP1 is one of the main regulators of synaptic 
plasticity 148,158,159. Its activation is required for LTD and strongly impairs LTP. Thus, 
targeting the PP2B/PP1 signaling cascade should be a promising avenue for potential 
treatments aiming at erasing LTP-associated fear conditioning by LTD-inducing fear 
extinction.  
The role of PP1 in hippocampal LTD has been explored mainly in relation to its ability to 
dephosphorylate AMPAR subunits, leading to receptor endocytosis 155-157. Additionally, its 
role in NMDAR-specific regulation during hippocampal LTD is also being explored 131,158. 
Our findings suggest a crucial function for PP1 in amygdalar LTD induced at both 
thalamic and cortical afferents. It would be interesting to further investigate the exact 
actions of PP1 on AMPAR and NMDAR subunits during LTD in the LA.  
PP1-mediated hippocampal LTD regulation 
The LTP/LTD-related phosphorylation and dephosphorylation events that regulate the 
trafficking and kinetic properties of the AMPARs and NMDARs (channel localization, 
conductance and opening probability) have been mostly studied in the CA1 hippocampal 
network 148,158,159,224. The phosphorylation of ionotropic glutamate receptors is mediated 
mainly by the serine/threonine kinases (STKs) whereas PPs are responsible for 
dephosphorylation.  
	   	  
	   	  	  	  	  
63	  
Both kinases and phosphatases are activated upon Ca2+ influx into a cell. While STKs are 
active upon a high Ca2+ influx through NMDARs, the PPs cascade is activated after a low 
and progressive Ca2+ influx into the postsynaptic cell, as induced for example during LFS 
149,150. Once activated upon PP2B-mediated I1 dephosphorylation during LTD, PP1 149,150 
reverses the STKs-mediated phosphorylation of AMPARs 224. Whether PP1 interacts with 
the NMDAR subunits during LTD is still unknown.  
Effects of PP1 on AMPAR 
In hippocampal LTD, PP1 specifically targets the GluR1 subunit of the AMPAR 155,156,224 
on two phosphorylation sites, the ser831 and ser845 224,225. Ser831 is a target of CaMKII 
and protein kinase C (PKC), whereas ser845 is specifically phosphorylated by cAMP-
dependent protein kinase A (PKA) 224,225. PKA-mediated phosphorylation regulates the 
open channel probability of the receptor, whereas the phosphorylation on ser831 
mediated by CaMKII controls the single-channel conductance of the channel 224,225. These 
two phosphorylation events occur during LTP 224, and cause an increase in synaptic 
transmission by augmenting the number of AMPARs on the cell surface of the pyramidal 
hippocampal neurons 226. Conversely, the dephosphorylation of these serine residues 
mediated by PP1 156 leads to the AMPAR down-regulation by 1) decreasing its opening 
probability and 2) weakening the stability of the receptor on the plasma membrane, 
leading to its internalization 155,156.  
Intriguingly, history of synaptic plasticity has a major impact on these specific PTMs 
occurring in LTP and LTD 224. For example, LTP induction in naïve synapses increases 
ser831 phosphorylation, whereas in previously depressed synapses, the same LTP 
protocol enhances ser845 phosphorylation 224. Similarly, in de novo LTD, PP1 
dephosphorylates only ser845 without altering the level of phosphorylation on ser831, 
while specific PP1-mediated ser831 dephosphorylation occurs during depotentiation 224. 
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In addition, the dephosphorylation of ser845 and ser831 during de novo LTD and 
depotentiation, respectively, is abolished by D-APV perfusion 157. As D-APV fully 
abolishes hippocampal LTD 149,150, this implies that dephosphorylation of AMPAR is an 
NMDAR dependent mechanism for LTD 157,224,226.  
Based on its importance in synaptic plasticity, the role of ser831 and ser845 
phosphorylation in memory has been assessed in various paradigms, including water 
maze for evaluating spatial memory, and fear conditioning for associative fear memory 
226,227. Genetically modified mice with a double phosphomutation for ser831 and ser845 
on the GluR1 subunit did not show any impairment in spatial learning compare to wild 
type littermates, but a defect in spatial memory retention after 8 to 24 hours after the 
behavioral paradigm 226. This alteration in spatial memory retention was correlated with 
the instability of LTP in the same mutant mice compare to littermates 226. Similar results 
were obtained in fear conditioning studies performed on mice injected with an antagonist 
peptide preventing GluR1 ser831 phosphorylation 227. In these mice, blocking GluR1 
phosphorylation did not affect fear memory and extinction but led to an impaired fear 
renewal after fear extinction 227. This is important, because fear renewal is one of the 
common relapse effects observed in patients treated with extinction-based exposure 
therapies 14,15. Fear renewal is mainly due to a change of context from where the therapy 
has been conducted to a context reminiscent of the traumatic experience. Whether GluR1 
subunit phosphorylation status affects other types of post-extinction relapse effects such 
as spontaneous recovery and reinstatement, remains to be elucidated.  
Nonetheless, preventing GluR1 phosphorylation could present a means to avoiding fear 
memory retention, and may prevent relapse after extinction. This is also in line with our 
hypothesis regarding enhancement of endogenous LTD and fear memory extinction by 
increasing endogenous PP1 activity and subsequent AMPAR dephosphorylation.  
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Effects of PP1 on NMDAR 
NMDAR phosphorylation/dephosphorylation events are required for NMDAR cell surface 
expression, trafficking, and stabilization at the synapse 100. The serine/threonine 
phosphorylation sites on NMDAR subunits have been identified as substrates for many 
kinases such as PKA, PKC, PKB, CaMKII, cyclin-dependent kinase-5 (Cdk5), and casein 
kinase II (CKII). In contrast, the dephosphorylation is mediated by PPs 129. The following 
section will present a brief overview of the PP1-mediated regulation of NMDAR subunits, 
focusing on NR2B and NR2C/D subunits, as we found them to be involved in amygdalar 
LTD. Importantly, no studies have yet reported a role of PP1 in dephosphorylating 
NMDARs during LTD. Most available studies have been performed in vitro without 
inducing any synaptic plasticity 124.   
CaMKII, PKC and CKII phosphorylate the NR2B subunit. The serine/threonine 
phosphorylation sites are ser1303, ser1323 and ser1480, where ser1303 is a target of 
CaMKII and PKC, ser1323 a target of PKC, and ser1480 a target of CKII. CaMKII and 
PKC phosphorylation potentiate NR2B-mediated NMDARs currents 228, whereas 
phosphorylation on the ser1480 regulates NR2B-containing NMDARs surface expression 
by disrupting the interaction between NR2B and PSD-95 229. While the phosphorylation 
status has been extensively studied on the NR2B subunit, which PPs is responsible for 
the subunit dephosphorylation remains still poorly understood. New evidences on cell 
culture showed an interaction between PP1 and NR2B 124,131. In these studies, PP1 was 
shown to be able to specifically dephosphorylate ser1303 leading to NR2B-containing 
NMDAR down-regulation, and a crucial role has been suggested for decreasing Ca2+ 
overload after ischemic conditions, thus conferring neuro-protection 124,131.  
PP1 dephoshorylation is specific to ser1303, since it does not perturb ser1323 and 
ser1480 131.  
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These results are compatible with previous results related to hippocampal LTD, as 
NMDAR-dependent LTD in this brain area does not involve NMDAR internalization, but its 
downregulation 158. Therefore, it may be interesting to further investigate the role of PP1 
on NR2B ser1303 phosphorylation status during LTD at the thalamic pathway. It is 
possible that during LTD, activated PP1 dephosphorylates AMPAR leading to its 
endocytosis, and may also interact with ser1303 on NR2B to promote its downregulation 
(most likely by interrupting the interaction of the subunit with CaMKII 230). Additionally, 
PP1 is also able to dephosphorylate CaMKII on its thr286, downscaling its activity 124,131. 
Little is still known about the regulation of the NR2C subunit by 
phosphorylation/dephosphorylation. However, recent studies identified two 
phosphorylation sites at ser1244 and ser1096. PKC and PKA phosphorylate ser1244, 
whereas PKB acts on ser1096 231. The phosphorylation on ser1244 may be important in 
modulating channel properties of the NMDAR, since non-functional mutated ser1244 
accelerates the kinetics of NMDA-evoked currents 231. On the other hand, 
phosphorylation of ser1096 regulates NMDAR binding to 14-3-3ε 231. 14-3-3ε belongs to a 
family of proteins able to mediate ER export of several proteins 119,231. Indeed, S1096A 
mutation reduces the surface expression of the NR2C-containing NMDARs, suggesting 
that PKB-dependent phosphorylation site is responsible for the NMDARs trafficking to the 
plasma membrane by regulating the interaction between NR2C and 14-3-3ε 231. Whether 
PP1 dephosphorylates NR2C at one of its serine residue remains unknown. No 
serine/threonine phosphorylation sites have yet been identified on the NR2D subunit 
108,119, thus any involvement of PP1 in NR2C dephosphorylation remains highly 
speculative.  
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In summary, upon NMDAR activation triggered by LTD induction, PP1 is activated and 
dephosphorylates many proteins involved in synaptic plasticity. Amongst them, the GluR1 
subunit has been extensively studied and is crucial for synaptic plasticity and related 
pathologies. Beside the AMPARs, NMDARs are also regulated by PP1. Interestingly, 
whereas both PP2B and PP1 are responsible for AMPARs internalization, only PP1 plays 
a role in NMDAR-EPSCs mediated hippocampal LTD 158. It may do so by interacting with 
NR2B ser1303 after LTD induction. However, this is still speculative. In addition, PP1 may 
interact with the NR2C subunit during LTD, since NR2C is involved in presynaptic LTD in 
the cortex 127,184 and in postsynaptic LTD in the hippocampus 118. This possibility has not 
been explored yet.  
D-cycloserine, an NMDAR agonist, has been used in pharmacotherapy associated with 
extinction-based exposure therapies in PTSD. Unfortunately, although this treatment 
brings improvements to the patient, it also shows strong side effects and does not prevent 
fear relapse 14,15. This failure may be due to the fact that activating NMDARs may lead to 
distinct kinds of synaptic plasticity in different regions. However, a strategy aimed at 
regulating endogenous PP1 activity specifically in the amygdala may improve extinction, 
while avoiding post-exposure relapse. This will require further investigations to clarify the 
exact role of PP1 in LTD at both thalamic and cortical pathways (see Outlook, Chapter 4). 
In my thesis, I investigated the molecular mechanisms underlying LTD in the LA. Below I 
present a hypothetical model of LTD occurring at thalamic and cortical inputs based on 
our results combined with data from the literature. 
NMDAR-DEPENDENT LTD SIGNALING CASCADE AT THALAMO-LA SYNAPSES 
The ppLFS at thalamo-LA synapses induces exclusively a postsynaptic LTD, undergoing 
a progressive and low postsynaptic Ca2+ influx through postsynaptic NR2B-containing 
NMDARs. This triggers a CaM signaling pathway 101,212,232 leading to activation of PP1 
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targeting complex, which likely contains A-kinase anchored protein (AKAP) as the PP2B 
and PP1 targeting protein and PKA as the protein kinase responsible for the I1 activation 
and GluR1 phosphorylation 233-236. The activation of PP1 is under the control of PP2B, 
which dephosphorylates I1 and PKA, leading to their inhibition. In turn, PP1 
dephosphorylates postsynaptic NR2B subunit at ser1303 and also GluR1 of the AMPARs. 
This leads to NMDARs down-regulation 131 responsible for LTD induction and AMPARs 
internalization 103,125 enabling LTD expression.  
NMDAR-DEPENDENT LTD SIGNALING CASCADE AT CORTICO-LA SYNAPSES 
LTD at the cortical input is more complicated since it involves presynaptic activity. The 
ppLFS at this pathway results in a presynaptic Ca2+ influx, likely through activation of 
presynaptic NR2C/D-containing NMDARs. As observed in the hippocampus, we 
hypothesize that the presynaptic increase in Ca2+ concentration may result in a rapid 
membrane depolarization, which will lead to the dephosphorylation of phosphatidylinositol 
4-phosphate 5-kinase c661 (PIP5Kg661; the major PI(4,5)P2-producing enzyme in the 
brain) 211. PIP5Kg661 is likely dephosphorylated by PP2B but not PP1 211. This process 
enables a decrease in neurotransmitter release by the recruitment of the clathrin-
mediated endocytotic machinery leading to the endocytosis of the synaptic vesicles 211. 
Since PP1 is not involved in the regulation of synaptic vesicle endocytosis 211, its role may 
be principally postsynaptic.  
In presynaptic LTD, a retrograde signaling mechanism may be required 74. Indeed, a 
retrograde endocannabinoid (eCB)-signaling involved in LTD has been observed in the 
LA 237-240. The eCB released from the postsynaptic compartment binds to its receptor 
(CB1R) that is localized at the presynaptic side 126. This binding may lead to presynaptic 
plasma membrane depolarization, leading to the activation of presynaptic NR2C/D-
containing NMDARs, thereby activating a presynaptic Ca2+ signaling cascade. Thus, the 
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role of PP1 at cortico-LA synapses may be in controlling eCB release from the 
postsynaptic compartment 241, since the AMPARs internalization does not seem to be 
required at this synapse 75. Nevertheless, we cannot exclude its role in the presynaptic 
compartment, maybe functioning in collaboration with PP2B, as PP2B may also be able 
to negatively regulate NR2C/D-containing NMDARs at the presynaptic site 213.  
I found that both PP2B and PP1 are necessary for LTD at both inputs to the LA, although 
probably localized differently within the respective synapses. PP2B and PP1 may also 
have a distinct role between both inputs. Overall, these findings combined with other 
studies in the field, may explain why thalamic and cortical afferents trigger distinct 
auditory or somatosensory information during fear conditioning. They may also explain, 
why an efficient therapy for PTSD still does not exist. As PP1 is activated at both 
pathways upon ppLFS, it is a promising future target in drug therapy for PTSD. Enhancing 
PP1 activity endogenously and specifically in the amygdala, as well as in the 
hippocampus and cortex, may strongly enhance fear extinction and avoid post-extinction 
relapse. The following chapter is designated to suggest some further experiments that 
could clarify the exact role of PP1 at both pathways during LTD.  
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CHAPTER 4: OUTLOOK 
In summary, the present experiments have shown the need of PP1 activation for LTD at 
both inputs to the LA. I also detected a different synaptic component of LTD at thalamic 
and cortical pathways, where LTD is postsynaptically and presynaptically induced at 
thalamo- and cortico- LA synapses, respectively. By blocking active NMDARs at the 
postsynaptic site, I further showed a distinct synaptic localization of the NMDARs at both 
inputs. Finally, by perfusion of different NR2 subunit antagonists, I observed a distinct 
NR2 subunit contribution to LTD; NR2B-containing NMDAR are localized at the thalamic 
pathway and NR2C- or NR2D- containing NMDARs at the cortical pathway. Taken 
together, the results of my thesis give rise, for the first time, to distinct molecular 
mechanisms of NMDAR-dependent LTD occurring at thalamic and cortical afferents to the 
LA, where PP1 is required for both.  
Follow-up experiments will be necessary to detail the mechanisms of action of PP1 in 
regulating LTD after NMDAR activation. For doing so, I propose to first further investigate 
the synaptic localization of NR2B, NR2C/D and PP1 by immunohistochemistry and 
immunogold labeling electron microscopy 123,242. The immunohistochemistry should be 
done on acute slices before and after the LTD induction protocol, by using subtype-
specific NR2 subunits antibodies and a specific PP1 antibody. The immunogold labeling 
is hardly possible to perform on acute slices, due to methodological issues. However, 
using this technique, one could identify the synaptic localization of NR2B, NR2C/D and 
PP1 on brains taken from mice previously subjected to fear extinction. This may confirm 
that LTD and fear extinction are strongly linked.   
Another interesting subject of investigation is whether PP1 dephosphorylates the GluR1 
subunit of the AMPAR at thalamo-LA synapses, as demonstrated in the hippocampus 224, 
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and / or if PP1 is able to dephosphorylate NR2B subunits at ser1303, or NR2C/D subunits 
during LTD.  
NR2B Ser1303 dephosphorylation mediated by PP1 has been shown in the hippocampus 
in vitro and in ischemic conditions, but has not been measured in response to LTD 131,243. 
At cortical input to the LA, PP1 may interact with NR2C/D subunits. Whereas NR2B 
ser/thr phosphorylation sites have been extensively studied in vitro (and only ser1303 can 
be dephosphorylated by PP1 131), NR2C ser/thr phosphorylation sites have just recently 
been described in the cerebellar cortex 231 and existing ser or thr sites on NR2D subunits 
remain still unexplored 108,119. On the NR2C subunit, there are two potential serine 
residues that may be dephosphorylated by PP1, ser1096 and ser1244. 
Dephosphorylation of these serine residues by PP1 may be associated with LTD at the 
cortical input to the LA, as dephosphorylation of one residue may lead to receptor 
endocytosis 244, and dephosphorylation of the other serine site may trigger its down-
regulation 231. PP1 dephosphorylation on NR2 subunits at either thalamic or cortical 
inputs can be assessed on protein extracts from amygdala slices by western blot analysis 
using subunit/serine residues-specific antibodies. Slices can be collected before or after 
LTD induction, either in the presence or in absence of PP1 antagonists such as 
tautomycetin, or using slices from mice where PP1 is genetically inhibited 139.  
As LTD, depotentiation and fear extinction require not only NMDARs but also mGluRs 
73,74, it would be interesting to extend the research on the role of PP1 in the LA-LTD also 
to mGluRs. Pharmacological or genetic inhibition of PP1 may be used in mGluR-
dependent LTD at both thalamic and cortical inputs. Group I mGluR involvement has 
been observed in LTD at thalamic inputs, whereas group II mGluR is required at the 
cortico-LA LTD 75,76.  
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Ultimately, as PP1 appears to be a main regulator of NMDAR-dependent LTD in the 
amygdala, in vivo behavior experiments should aim at increasing PP1 activity in the LA to 
test whether fear extinction can be enhanced and fear relapse can be avoided.  
A POSSIBLE ROLE FOR EPIGENETIC REGULATION OF PP1 
In addition to the acute effects of PP1 signaling, studying the epigenetic regulation of PP1 
in amygdalar neurons during and following LTD may also lead to a better understanding 
of the molecular mechanisms of fear-related psychiatric diseases, such as PTSD. It is 
known that the Ca2+ entry through NMDARs results in the activation of specific signaling 
pathways leading to changes in gene expression (such as CREB), enabling long-term 
maintenance of memory. Those changes are mediated by epigenetic mechanisms, 
including histone acetylation, methylation and phosphorylation, and they are associated 
with transcriptional activation 245. In the hippocampus, one of the key roles of PP1 in 
mediating epigenetic changes is its dephosphorylation of the histone 3 on the serine 
residue 10 at the CREB promoter site 135, enabling an increase of CREB expression, 
which regulates transcription of downstream genes involved in synaptic and structural 
plasticity. Similar findings were reported also in the lateral nucleus of the amygdala, 
where the specific inhibition of a nuclear pool of PP1 was shown to increase LTP when 
induced at the cortical input. This LTP enhancement was correlated with an increased 
phosphorylation of H3S10, with increased CREB expression and with enhanced memory 
on contextual and cued fear conditioning tasks 133. These results suggest that PP1-
dependent chromatin regulation may underlie disorders affecting emotional memory, by 
acting in several brain regions such as the hippocampus and the amygdala 246,247. 
While epigenetic mechanisms have been implicated in numerous neurological and 
psychiatric disorders, such as Alzheimer’s disease, schizophrenia and depression 248, 
there is still no firm evidence for a direct involvement of epigenetic processes in PTSD. 
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Nevertheless, Yehuda and Bierer have reported that the risk of having PTSD is 
associated with childhood adversity and PTSD in mothers 249, suggesting long-term, 
potentially heritable effects of childhood adversity on disease risk. Such long-term risk 
likely depends on epigenetic regulation, possibly also in germcells 250,251. In our lab, we 
have developed a mouse model of early life traumatic stress to investigate the 
transmission of disease risk from parents to offspring. This model exposes mice to 
unpredictable maternal separation combined with maternal stress (MSUS) during the first 
two weeks of life. The effects of the early life traumatic experience are then assessed in 
adult mice that were directly exposed to maternal separation paradigm when they were 
pups (F1 generation), but also in their non-stressed offspring (F2 generation) generated 
by mating F1 males to unstressed naïve females. Across generations, MSUS mice 
display a wide array of behavioral disturbances, ranging from depressive-like behaviors to 
altered anxiety responses, impaired social interaction as well as impairments in cognitive 
function 252-255. I have contributed to a recent project that demonstrated that MSUS mice 
display pronounced alterations in synaptic plasticity in the hippocampus and amygdala of 
both the directly exposed mice (F1) and their non-stressed F2 offspring 256 (see Chapter 5 
below). 
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In agreement with the observed alterations in synaptic plasticity, gene expression and 
DNA methylation analyses showed marked differences between the offspring of MSUS 
and control fathers. These analyses identified two molecular pathways involving calcium-
mediated RAS activation and CaMKII-dependent CREB phosphorylation, which were 
suppressed in F2 MSUS offspring. It is possible that PP1 may be involved in the MSUS-
induced plasticity effects. Pharmacological inhibition of PP1 during LTP experiments in 
MSUS and control mice could be used to test this possibility, which would represent the 
first evidence for a transgenerational role of PP1 regulation, with possible clinical 
implications for PTSD. 
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CHAPTER 5: OTHER PROJECTS 
 
This chapter contains two publications to which I contributed significantly. 
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Abstract 
Alzheimer’s disease (AD), the most common neurodegenerative disorder, goes along with 
extracellular amyloid-β (Aβ) deposits. The cognitive decline observed during AD 
progression correlates with damaged spines, dendrites and synapses in hippocampus 
and cortex. Numerous studies have shown that Aβ oligomers, both synthetic and derived 
from cultures and AD brains, potently impair synaptic structure and functions. The cellular 
prion protein (PrPC) was proposed to mediate this effect. We report that ablation or 
overexpression of PrPC had no effect on the impairment of hippocampal synaptic 
plasticity in a transgenic model of AD. These findings challenge the role of PrPC as a 
mediator of Aβ toxicity. 
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Introduction 
Alzheimer’s disease (AD) is an age-dependent neurodegenerative disorder that 
culminates in cognitive decline with limited treatment options. Oligomeric amyloid-β (Aβ), 
derived from the b and g cleavage of b-amyloid precursor protein (APP), may drive AD 
pathogenesis by activating ill-defined signaling pathways (Walsh et al, 2005). Several 
molecules have been suggested to trigger the latter (De Felice et al, 2009; Shankar et al, 
2007; Snyder et al, 2005). The cellular prion protein (PrPC) was reported to mediate the 
impairment of long-term potentiation (LTP) induced by synthetic Aβ oligomers in the 
hippocampal Schaffer collateral pathway (Lauren et al, 2009). Also, removal of PrPC from 
mice carrying APPswe and PSen1ΔE9 transgenes rescued early death and memory 
impairment (Gimbel et al, 2010). 
PrPC is a membrane-anchored glycoprotein (Steele et al, 2007) crucial for axomyelinic 
integrity of peripheral nerves (Bremer et al, 2010). The remarkable finding that PrPC 
mediates Aβ-related synaptic toxicity was taken to suggest that interference with PrPC 
may represent a therapeutic option for AD (Lauren et al, 2009; Gimbel et al, 2010). 
However, upon intracerebral injection of synthetic Aβ oligomers, the absence of PrPC did 
not prevent deficits in hippocampal dependent behavioral tests (Balducci et al, 2010). 
In view of these conflicting reports, we reasoned that a better understanding of the impact 
of PrPC onto AD may come from careful genetic analyses. Also, the utilization of a 
second, independent AD transgenic mouse model may help evaluating the universality of 
the observed phenomena. We therefore asked whether PrPC would modulate the 
degradation of LTP in an in vivo model of AD.  
We crossed mice lacking (Buëler et al, 1992) or overexpressing membrane-anchored 
(Fischer et al, 1996) or secreted PrP (Chesebro et al, 2005) with APPPS1+ mice 
coexpressing mutant APP (APPKM670/671NL) and mutant presenilin-1 (PS1L166P; 
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Radde et al, 2006) which suffer from Aβ-dependent learning and memory deficits 
(Serneels et al, 2009; Table 1). We found that ablation or overexpression of PrPC had no 
effect on the impairment of hippocampal synaptic plasticity in a transgenic model of AD. 
These findings challenge the role of PrPC as a Aβ toxicity mediator. 
Results and Discussion 
LTP IMPAIRMENT AND APP PROCESSING ARE NOT ALTERED IN ABSENCE OF THE CELLULAR PRION 
PROTEIN 
We crossed Prnpo/o mice lacking PrPC (Buëler et al, 1992) with APPPS1+ mice 
coexpressing mutant APP (APPKM670/671NL) and mutant presenilin-1 (PS1L166P; 
Radde et al, 2006).  
 
The resulting mice did not display any early death independently of the Prnp genotype 
(data not shown). High-frequency stimulation (HFS) of Schaffer collateral CA1 synapses 
induced an increase in field excitatory postsynaptic potentials (fEPSP) reflecting LTP in 
both 4-month-old Prnp+/+ and Prnpo/o mice (data not shown) as previously reported 
(Lledo et al, 1996). In contrast, age-matched APPPS1+Prnp+/+ (n = 6), APPPS1+Prnp+/o 
(n = 5) and APPPS1+Prnpo/o (n = 5) all exhibited defective LTP after HFS (114.23 ± 
9.61; 111.72 ± 9.64 and 105.51 ± 12.23%, respectively; p < 0.001; Fig 1A). The fEPSP 
slopes during the first 2 min were similar in APPPS1+Prnp+/+ and wild-type mice (124.1 ± 
7.0 and 184.8 ± 26.2%, respectively; p > 0.05), indicating that immediate post-tetanic 
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potentiation was not affected.  
Basal synaptic transmission as assessed by input–output curve analysis was normal in all 
mice (Fig 1B and C), confirming that the APPPS1 transgene induces a selective 
impairment in synaptic plasticity. In contrast to 4-month-old animals, robust LTP was 
induced in 2-month-old APPPS1+Prnp+/+ (172.6 ± 14.6%; n = 5), APPPS1+Prnp+/o 
(168.9 ± 14%; n = 5) and APPPS1+Prnpo/o mice (204.4 ± 15.9%; n = 4) and was 
comparable to LTP in Prnp+/o (174.6 ± 7%; n = 5; Fig 1D). We conclude that the LTP 
impairment was age related, appeared only in mice carrying the APPPS1 transgene after 
>2 months, and was independent of Prnp gene dosage. 
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Figure 1. CA1 hippocampal LTP impairment in APPPS1+ mice occurs at 4 months of age and is not 
regulated by PrPC expression.  
A. CA1 hippocampal LTP was induced in acute slices from 4-month old Prnp+/+ mice 
(black, n = 7), but was abolished in slices from age-matched APPPS1+Prnp+/+ (dark blue, 
n = 6), APPPS1+Prnp+/o (blue, n = 5) and APPPS1+Prnpo/o mice (light blue, n = 5). B. 
fEPSP traces before (red) and after (black) LTP induction. Calibration: 1 mV; 10 ms. C. 
Input–output curves (stimulus intensity vs. fEPSP slope) indicative of normal basal 
synaptic transmission. D. Unaffected LTP in slices derived from 2-month-old 
APPPS1+Prnp+/+ (n = 5), APPPS1+Prnp+/o (n = 5), APPPS1+Prnpo/o (n = 4) and Prnp+/o 
mice (n = 5). These results indicate that LTP impairment in APPPS1+ mice was not a 
developmental defect, and occurred only after 2 months of age independently of Prnp 
gene dosage. 
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Many genetic polymorphisms affect APP processing and Aβ levels (Lehman et al, 2003). 
The APPKM670/671NL and PS1L166P transgenes map to mouse chromosome 2 
(Mmu2; Radde et al, 2006) along with Prnp, and are linked to a quantitative trait locus that 
modifies Aβ levels (Ryman et al, 2008). Furthermore, PrPC itself was reported to directly 
interfere with APP catabolism (Parkin et al, 2007). Each of these factors, alone or in 
combination may modulate the production of soluble Aβ42, thereby indirectly affecting 
LTP impairment. However, we found that 2-month old gender-matched APPPS1+Prnp+/+ 
and APPPS1+Prnpo/o mice displayed similar levels of APP catabolites (Fig S1A) and 
soluble Aβ42 (Fig S1B). We conclude that the effects described here cannot be ascribed 
to any difference in APP generation or processing. 
EVALUATION OF GENETIC CONFOUNDERS THAT MIGHT MASK THE IMPACT OF PRPC ON LTP IN 4-
MONTH-OLD APPPS1 MICE 
A genome-wide screen of 192 polymorphic microsatellites revealed that 
APPPS1+Prnpo/o mice contained significantly larger portions of 129/Sv-derived genome 
than APPPS1+Prnp+/+ mice (129/Sv-specific markers: average ± SEM: 60 ± 6.2 vs. 
2 ± 0.4, respectively; p < 0.001). This genetic constellation may be taken to suggest that 
the above intercrosses have inadvertently introduced genetic biases affecting LTP 
independently of Aβ levels (Gerlai, 2002). However, in subsequent intercrosses, the 
content in genome-wide 129/Sv-specific markers was 55.3 ± 3.9 versus 41.7 ± 3.2 (n = 7 
and 6, respectively; p < 0.05), yet this statistically significant difference disappeared upon 
exclusion of markers on Mmu2 (44.7 ± 3.8 vs. 38.0 ± 3.2, respectively; p > 0.05).  
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This indicates that the latter mice, although not inbred, were genetically similar except 
for the Mmu2 genomic region that is closely linked to both Prnp and APPPS1 and does 
not desegregate easily from these loci by breeding. This genetic scenario may help 
explaining the differences in insoluble Aβ42 levels seen in F2 APPPS1+ mice with 
different Prnp genotypes generated by intercrosses of APPPS1+ and Prnpo/o mice (Fig 
S2; Ryman et al, 2008). 
TRANSGENIC PRPC OVEREXPRESSION DISPROVES MMU2 BIAS AND DOES NOT AGGRAVATE 
APPPS1-INDUCED LTP IMPAIRMENT 
To formally discriminate between PrPC-dependent effect and potential confounders 
residing on Mmu2, we reintroduced PrPC into APPPS1+Prnpo/o mice via crosses to 
tga20 mice (Fischer et al, 1996) that carry a Prnp minigene on Mmu17 (Zabel et al, 2009) 
and overexpress PrPC about fourfold (Fig S3). LTP was again affected in 4-month-old 
APPPS1+tga20tg/−Prnpo/o (127.84 ± 12.61%; n = 4) and APPPS1+tga20-/-Prnpo/o 
littermates (106.56 ± 5.46%; n = 5; p = 0.137; Fig 2A). The genome-wide microsatellite 
patterns of these two groups of mice were indistinguishable even when Mmu2 markers 
were included (129/Sv-specific markers: 61.0 ± 2.1 vs. 61.7 = 3.9, respectively; p > 0.05; 
Fig 2B), indicating that any contribution by genetic confounders to the phenotype is 
unlikely.  
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Figure 2.  LTP in 4-month-old APPPS1 mice expressing a PrPC transgene.  
A. At 4 months of age, LTP was impaired in slices from both APPPS1+tga20tg/-Prnpo/o (n = 4) and 
APPPS1+tga20-/-Prnpo/o (n = 5) but not in Prnp+/+ slices (n = 7; LTP mean ± SEM from Fig 1A represented 
as grey ribbon). Basal synaptic transmission was normal as indicated by normal input– output curve 
(stimulus intensity vs. fEPSP slope). B. Average fEPSP slopes (percentage of baseline) at 10–25 min post-
LTP plotted against the average number of 129/Sv specific markers for mice depicted in panel A and Fig 
1A. In all investigated paradigms, LTP suppression by the APPPS1 transgene was independent of the 
genetic background. 
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To further explore the impact of supraphysiological levels on PrPC in LTP, we analyzed 
APPPS1+tga20tg/-Prnp+/o, which overexpress ca. sevenfold PrPC (Fig S3) and 
APPPS1+tga20-/-Prnp+/o littermates. These two groups of mice shared similar genomic 
microsatellite patterns (Fig 3A).  
At 4 months of age, LTP was significantly reduced in both APPPS1+tga20tg/-Prnp+/o and 
APPPS1+tga20-/-Prnp+/o littermates (149.41 ± 11.81%, n = 6 vs. 121.56 ± 11.65%, 
respectively; n = 4; Fig 3B). Expression of the tga20  allele showed a tendency 
towards improved LTP that was not statistically significant, without altering APP 
catabolites and soluble and insoluble Aβ42 (Fig 3C and D). Therefore, PrPC 
overexpression did not enhance Aβ-mediated LTP impairment; if anything, it may have 
marginally antagonized it. 
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Figure 3. Analysis of 4-month-old APPPS1+ mice with supraphysiological levels of PrPC.  
A. Percentage of strain-specific microsatellites in APPPS1+tga20tg/-Prnp+/o (n = 6) and APPPS1+tga20-/-
Prnp+/o (n = 4) mice is displayed by box plot. No significant difference in the genetic background of the two 
mouse strains was detected (Mann–Whitney U-test, two-tailed, p > 0.05). B. At 4 months of age, slices of 
both APPPS1+tga20tg/-Prnp+/o (n = 6) and APPPS1+tga20-/-Prnp+/o mice (n = 4) displayed reduced LTP when 
compared to Prnp+/+ mice (n = 7); LTP mean ± SEM from Fig 1A represented as grey ribbon. Basal synaptic 
transmission was normal as indicated by normal input–output curve (stimulus intensity vs. fEPSP slope). All 
error bars: standard errors of the mean. C. APP expression and processing by secretases were similar in 4-
month-old APPPS1+tga20tg/-Prnp+/o and APPPS1+tga20-/-Prnp+/o mice. Left panel: representative SDS–
PAGE followed by immunoblotting using an APP C-terminal antibody detecting full-length APP and αβ-CTF; 
actin was used as loading control. Right panel: quantitation of chemiluminescence for APP, α-CTF and β-
CTF. D. TRIS-soluble (left panel), detergent-soluble (middle panel) and insoluble (right panel) human Aβ42 
levels as assessed by ELISA. Each symbol denotes one individual mouse. 
OVEREXPRESSION OF A SECRETED PRPC VARIANT REDUCED THE IMPAIRMENT OF LTP IN 4-
MONTH-OLD APPPS1 MICE 
We next asked whether a soluble version of PrPC might intercept Aβ oligomers and 
interfere with synaptic toxicity. First we verified that interaction of PrPC with Aβ species 
(Balducci et al, 2010; Lauren et al, 2009) can occur in the absence of PrPC membrane 
anchoring. We therefore tested the binding properties of bacterially expressed 
recombinant full-length PrP (recPrP23–230). We found that recPrP23–230 bound low 
molecular weight Aβ42 species, and that binding was reduced by monoclonal anti-PrP 
antibodies (Polymenidou et al, 2008) raised against its N-proximal region (Fig S4). Also, 
we found that a shortened variant of recPrP lacking the amino-proximal residues 23–121 
(recPrP121–230) did not bind Aβ42 (Fig S4). These results confirm that PrP, even when 
produced in bacteria and therefore, lacking all eukaryotic post-translational modifications 
including the addition of a glycolipid anchor, can efficiently bind Aβ species. 
We then crossed APPPS1+Prnpo/o mice to mice expressing GPI-anchorless PrP 
(secPrP), which is secreted into body fluids of tg44Prnp-/- transgenic mice (Chesebro et 
al, 2005). The Prnpo and Prnp- alleles refer to the ‘Zurich-I’ (Buëler et al, 1992) and 
‘Edbg’ (Manson et al, 1994) gene ablation events. We measured LTP in hippocampal 
slices derived from 4-month-old APPPS1+tg44tg/-Prnp-/o (n = 7) and APPPS1+tg44-/-
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Prnp-/o (n = 6) littermates with comparable genomic microsatellite patterns (Fig 4A). 
Remarkably, secPrP significantly suppressed the APPPS1-related LTP impairment (151.5 
± 11 and 108.5 ± 7.5%, respectively; p < 0.05, ANOVA and Tukey’s multiple comparison 
test, see Fig 4B). The metabolism of APP and the levels of soluble and insoluble Aβ42 did 
not appear to be altered by the tg44 transgene (Fig 4C and D), suggesting that secPrP 
exerted its beneficial effects interfering with the effectors of Aβ toxicity. 
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Figure 4. Anchorless soluble PrPC reduces hippocampal LTP impairment in APPPS1+ mice.  
A. Percentage of strain-specific microsatellites in APPPS1+tg44tg/-Prnp-/o (n = 5) and APPPS1+tg44-/-Prnp-/o 
(n = 5) mice is displayed by box plot. No significant difference in the genetic background was detected 
(Mann–Whitney U-test, two-tailed, p > 0.05).  
B. LTP was induced in slices prepared from 4-month-old tg44tg/-Prnp-/o (n = 5) and tg44-/-Prnp-/o (n = 7) mice, 
but was impaired in slices from APPPS1+tg44-/-Prnp-/o mice (n = 6) and partially rescued in APPPS1+tg44tg/-
Prnp-/o (n = 7) mice. Basal synaptic transmission was normal as indicated by normal input–output curve 
(stimulus intensity vs. fEPSP slope). All mice were compound heterozygotes for the ‘Zurich-I’ (Prnpo) and 
the ‘Edbg’ (Prnp-) knockout alleles of Prnp. C. APP expression and processing by secretases were similar 
in APPPS1+tg44tg/-Prnp-/o and APPPS1+tg44-/-Prnp-/o mice at 4 months of age. Left panel: representative 
SDS–PAGE followed by immunoblotting using an APP C-terminal antibody detecting full-length APP and C-
terminal fragments (αβ-CTF); actin was used as loading control. Right panel: quantitation of 
chemiluminescence revealed no difference in APP, α-CTF and β-CTF between the two groups. D. TRIS-
soluble (left panel), detergent-soluble (middle panel) and insoluble (right panel) human Aβ42 levels as 
assessed by ELISA. Each symbol denotes one individual mouse. 
 
Despite decades of research, the cascade of events that originates with the aggregation 
of Aβ and leads up to cognitive impairment continues to be poorly understood. Many 
observations point to a crucial role of transmembrane signaling events triggered by 
aggregated Aβ. Several membrane proteins have been reported to bind soluble Aβ 
oligomers — thereby candidating as potential transducers of toxicity (Deane et al, 2004; 
De Felice et al, 2009; Shankar et al, 2007; Snyder et al, 2005; Yan et al, 1996). A great 
deal of excitement was generated by the recovery of PrPC from an expression screen for 
soluble Aβ oligomer binders, particularly as synthetic soluble Aβ oligomers were found to 
damage hippocampal LTP in a PrPC-dependent manner (Lauren et al, 2009) and 
impairment of spatial memory was rescued by genetic ablation of PrP in a mouse model 
of AD (Gimbel et al, 2010). However, the report that removal of PrPC did not prevent the 
behavioral deficits caused by intracerebral injection of synthetic Aβ oligomers (Balducci et 
al, 2010) challenged the role of PrPC as a crucial mediator of Aβ synaptotoxicity. 
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We crossed mice expressing human Aβ to mice lacking or overexpressing PrPC or a 
soluble variant thereof to evaluate if the impact of PrP is persistent also in another AD 
mouse model which suffer from Aβ-dependent learning and memory deficits (Serneels et 
al, 2009). The latter experimental paradigm may more closely approximate the human 
disease than the previously published models (Balducci et al, 2010; Lauren et al, 2009) 
as exposure to Aβ species is chronic and uninterrupted over a protracted period, which is 
arguably more realistic than hyperacute exposure of brain tissue to Aβ. Furthermore, Aβ 
exists in AD brains as a vastly heterodisperse spectrum of assemblies ranging from 
monomers and dimers to oligomers and extremely large fibrillary aggregates, each one of 
which may partly contribute to the AD phenotype (Lesne et al, 2006; Shankar et al, 2008, 
2009; Walsh et al, 2002).  
As the relative affinity of the various Aβ assemblies for PrPC is not known in detail, 
transgenic mice expressing many such assemblies may reveal phenomena that might go 
unrecognized in simpler systems, such as application of defined synthetic Aβ oligomers. 
On the other hand, the genetic crosses described in our study and in previous work 
(Gimbel et al, 2010) may suffer from limitations. PrPC was reported to regulate β-
secretase cleavage (Parkin et al, 2007), and overexpression may interfere with APP 
metabolism and Aβ levels, thereby indirectly affecting LTP impairment. Indeed, careful 
genetic quality control revealed a mouse-strain dependent effect on insoluble Aβ42 levels 
— a phenomenon that should be taken into account while interpreting results from mouse 
AD models. However, all mice analyzed in this study displayed similar levels of APP 
catabolites and Aβ42 independently of Prnp gene dosage. We also considered the 
possibility that potential confounders residing on Mmu2 might have introduced alterations 
of the experimental evaluation (Steele et al, 2007), a problem, which remains unsolved in 
the study by Gimbel et al. However, in our paradigm, genome-wide microsatellite 
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analyses and expression of PrPC from the tga20 minigene on chromosome Mmu17 
disproved any Mmu2 bias. 
Additionally, one might argue that the exceedingly rapid amyloid pathology of APPPS1 
mice used in our study leads to irreversible synaptic damage that is independent of Aβ 
oligomers and, consequently, of PrPC. However, the original report (Radde et al, 2006) 
and our observations indicate that immunohistochemically and biophysically recognizable 
amyloid deposition does not occur in APPPS1 hippocampi before 4–5 months of age (Fig 
S5). Therefore, at the time of our analysis, there was no massive amyloid deposition in 
the hippocampus. Furthermore, the rescue of LTP impairment by secPrP negates the 
possibility that an overly aggressive amyloid pathology precludes the evaluation of the 
role of PrPC in these mice. 
The combined weight of all these results favours the conclusion that, however enticing, 
the hypothesis of PrPC being a crucial mediator of Aβ synaptotoxicity might be not 
universal. 
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Supplementary information 
Supplementary Figure: 
 
 
Figure S1. APP expression and processing in APPPS1+ mice is not affected by Prnp genotypes. 
APP expression and processing by secretases were similar in 2-month-old APPPS1+Prnp+/+, 
APPPS1+Prnp+/o and APPPS1+Prnpo/o mice. (A) Full-length APP and C- terminal fragments (α-β CTF) 
are not affected by Prnp genotype. Left panel: representative SDS-PAGE followed by immunoblotting using 
an APP C-terminal antibody detecting full- length APP and α-β CTF; actin was used as loading control. 
Right panel: quantitation of chemiluminescence for APP, α-CTF and β-CTF. (B) Human soluble Aβ42 levels 
as assessed by ELISA. Each symbol indicates a mouse. 
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Figure S2. Genetic background associates with differences in insoluble Aβ42 levels in APPPS1+ mice. 
APPPS1+ mice (on a C57B/6 background) were crossed with Prnpo/o mice (on a mixed C57BL/6 and 
129/Sv background) to generate F1 and F2 mice as depicted in the pedigree. Insoluble Aβ42 levels are 
plotted against the number of 129/Sv specific microsatellite markers. Each symbol denotes a mouse. 
Average ± standard deviation for each group is displayed as well. 
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Figure S3. Overexpression of PrP in APPPS1+ mice.  
Expression of PrPC in brains from APPPS1+Prnp+/+, APPPS1+tga20tg/-Prnpo/o and APPPS1+tga20-/-
Prnp+/o mice were analyzed by ELISA. Each symbol indicates a mouse. Significance was determined by 
one-way ANOVA *p< 0.05. 
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Figure S4. Recombinant PrP binds synthetic Aβ42 through its amino proximal domain.   
(A) SDS-PAGE followed by protein blotting with an anti-human Aβ (6E10) antibody was used to 
characterize Aβ42 preparations (20, 10 or 5 ng of synthetic protein in each lane) for the experiments (B-D). 
(B) Titration of human Aβ42 onto immobilized recombinant PrP (recPrP23-231) obtained by ELISA showed 
binding of recPrP23-231 to Aβ42. (C) Binding of human Aβ42 to recPrP121-231 was reduced in presence 
of the POM2 and POM3 antibodies against the N-proximal region of PrPC. The epitope of POM2 lies within 
the octapeptide repeat region of PrPC, giving rise to four binding sites between residues 58 and 88. The 
epitope recognized by POM3 corresponds to amino acids 95-100 of mouse PrP. POM2, POM3, and IgG1 
isotype control were utilized at different concentrations (100nM, 10nM, 1nM). Values are averages ± SD. 
Significance was determined by one-way ANOVA ***p < 0.001. (D) Comparison between the binding curves 
for human Aβ42 to immobilized recPrP23-231 or truncated recPrP121-231. Removal of the N-terminal 
region, as in recPrP121-231, prevented binding to Aβ42. 
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Figure S5. Amyloid pathology and associated inflammatory response.  
Hippocampi of 4- month-old wild-type mice (1st row) and various APPPS1 mice (rows 2-5). The APPPS1 
mice displayed similar degree of amyloid deposition, microglial activation, and astrocytosis. A 12- month-old 
APPPS1+tga20tg/-Prnp+/o mouse (bottom row) showed more pronounced amyloid deposition and 
associated inflammatory responses. HE: hematoxilin/eosin; Iba1: microglial marker; GFAP: glial fibrillary 
acidic protein, a marker of reactive astrocytes. Scale bar: 500 µm. 
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Figure S6. Crossing of genetically modified mice 
used in this study.  
A representative pedigree showing intercrossing of 
several mutant mice is depicted. Grey scale 
indicates different levels of PrPC. Brown symbol: 
designate expression of anchorless, soluble PrP. 
The orange border denotes the presence of 
APP/PS1 transgenes. Parallel lines indicate brother- 
sister crossing. APPPS1- mice are not represented 
(with one exception) in the pedigree for clarity, but 
were included as controls in the actual experiments. 
Prnpo and Prnp- denote by convention the “Zurich-I” 
and “Edbg” knockout alleles of Prnp, respectively. 
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Material and Methods 
Mice 
To remove the prion protein locus (Prnp), Prnpo/o mice (Büeler et al, 1992) were crossed 
with APPPS1 mice (Radde et al, 2006). APPPS1+Prnpo/o or APPPS1 mice were then 
crossed with tga20tg/-Prnpo/o (Fischer et al, 1996) or tg44tg/-Prnp-/- mice (Chesebro et 
al, 2005) to generate the different APPPS1+ and APPPS1- littermate control mice (Table 
1 and Fig S6). The genetic pattern of mouse strains was determined with a panel of 192 
polymorphic microsatellites as described (Bremer et al, 2010). All mice were maintained 
under specific pathogen-free conditions. Housing and experimental protocols were in 
accordance with the Swiss Animal Welfare Law and in compliance with the regulations of 
the Cantonal Veterinary Office, Zurich. 
Electrophysiology 
Hippocampal slice preparation from male mice and fEPSPs recordings in the CA1 region 
were as described (Knobloch et al, 2007). The LTP induction protocol was considered 
successful, and entered in the analysis, only if a stable baseline for at least 10 min was 
achieved. To generate input–output curves, slices were prepared as above and 
stimulated every 20 sec with increasing intensity (from 0.0 to 0.1 mA in 0.01 mA 
increments) using a total of 10 stimuli. For comparing groups, potentiation of fEPSP 
slopes during the interval 10–25min post- tetanus was evaluated. Data points were 
normalized to the mean baseline value and expressed as mean ± SEM. All numbers in 
brackets indicate analyzed mice; 2–3 slices were typically analyzed for each mouse. 
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Tissue preparation 
Brain fractionation was performed as described (Shankar et al, 2008) with modifications. 
Briefly, snap frozen forebrains were homogenized in ice-cold tris buffered saline (TBS), 
after centrifugation at 100,000 × g for 1 h the supernatant (called soluble fraction) 
was used to determine soluble Aβ42. The pellet was homogenized in phosphate buffered 
saline plus 0.5% 4-nonylphenyl-polyethylene glycol (NP40S), 0.5% 3-[(3-
cholamidopropyl) dimethylammonio]-1- propanesulfonate (CHAPS) and spun at 
16,000 × g for 30 min. The resultant supernatant was used to quantify APP, α-C 
terminal fragment (CTF) and β-CTF and the remaining pellet was solubilized in 70% 
formic acid and insoluble Aβ42 was measured after tris(hydroxymethyl)aminomethane 
(TRIS)-base neutralization. 
Quantification of Aβ42 and PrPC 
Levels of Aβ42 were assessed by sandwich enzyme-linked immunosorbent assay 
(ELISA; hAmyloid Aβ42, The Genetics Company) according to manufacturer’s 
instructions. PrPC concentration was determined by sandwich ELISA as described 
(Polymenidou et al, 2008). 
Immunoblotting 
To determine APP and CTFs levels, 20 mg of proteins were separated by electrophoresis 
on a 4–12% polyacrylamide gel. Primary antibodies were: anti-APP C-terminal (Sigma) 
recognizing both mouse and human APP and CTFs; anti-actin (Chemicon). Protein bands 
were detected by adding SuperSignal West Pico Chemiluminescent Substrate (Pierce) 
and exposing the blot in a Stella detector (Raytest). Chemiluminescence quantification 
was performed by TINA software. 	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In vitro binding assay 
Binding of synthetic human Aβ42 (Bachem AG) to immobilized recombinant PrP (Zahn et 
al, 1997) was analyzed by ELISA. Recombinant PrP (recPrP23–231 or recPrP121–231) 
was immobilized overnight at 48C on 96-well microtiter plates. Varying concentrations of 
synthetic human Aβ42 were added to wells and incubated for 1 h. Bound proteins were 
detected by incubation with 6E10 antibody (Covance) followed by horseradish 
peroxidase-conjugated antimouse IgG1. Absorbance was measured at 450 nm. For 
Western blot analysis various concentrations of Aβ42 were incubated in the same 
conditions, followed by Sodium dodecyl sulphate–polyacrylamide gel electrophoresis 
(SDS–PAGE) and blotting with 6E10 antibody. Binding of human Aβ42 (25 nM) to 
recPrP23–231 was assessed also in presence of decadic dilutions (100, 10 and 1nM) of 
anti-PrP antibodies (Polymenidou et al, 2008). 
Histological analyses 
Brains were removed and fixed in 4% formaldehyde in phosphate buffered saline, pH 7.5, 
paraffin embedded and cut into 2–4mm sections. Sections were stained with 
hematoxylin–eosin (HE) or antibodies against glial fibrillary acidic protein (GFAP) 
(DAKO), ionized calcium binding adapter molecule 1 (Iba1; WAKO) and Aβ (4G8; Signet). 
Statistical analyses 
Statistical significance was determined according to one-way ANOVA followed by Tukey’s 
post-test for multiple comparison, unpaired Student’s t-test and Mann–Whitney test using 
Prism software (GraphPad Software). Error bars in the graphs and numbers following the 
± sign denote standard errors of the mean unless otherwise indicated. 
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Abstract 
Traumatic stress in early life increases the risk for cognitive and neuropsychiatric 
disorders across life. Through epigenetic mechanisms, such experiences can also impact 
the progeny even if not directly exposed to stress. Here, we report in mice that the adult 
offspring of stressed males have altered molecular pathways necessary for neuronal 
signaling, and dysfunctional synaptic plasticity. Specifically, long-term potentiation is 
abolished and long-term depression is enhanced in the hippocampus. These defects are 
associated with impaired long-term memory in both the offspring and the stressed fathers. 
The brain-specific gamma isoform of protein kinase C (Prkcc) is one of the affected 
signaling components in the hippocampus. Its expression is reduced in the offspring, and 
DNA methylation at its promoter is altered both in the hippocampus of the offspring and 
the sperm of fathers. These results suggest that postnatal traumatic stress in males can 
affect brain plasticity and cognitive functions in the progeny when adult, likely through 
epigenetic changes in the male germline. 
Introduction 
Early life stress resulting from emotional and physical neglect or abuse in childhood is a 
major risk factor for the development of psychiatric conditions such as major depression, 
bipolar disorder, schizophrenia and post-traumatic stress disorder 258. Considering that 
about 700,000 children are victims of neglect or abuse each year in the United States 
alone 259,260, the long-term consequences of such trauma place a heavy burden on 
society and the healthcare system. Recent studies in mice have demonstrated that 
exposure of male pups to traumatic stress involving repeated episodes of unpredictable 
maternal separation combined with maternal stress (MSUS), leads to depressive-like 
behaviors, altered risk assessment and impaired social interactions in adulthood across 
several generations 261-263. This suggests that paternal trauma is a risk factor for the 
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development of behavioral disorders in the progeny 251,264. In addition to affective and 
emotional disorders, cognitive dysfunctions are also common to many stress-induced 
conditions 260,265-267, in part because the hippocampus, a brain region critical for learning 
and memory formation, is an important component of stress response pathways 268,269. 
Animal models have established that early trauma can have lifelong negative 
consequences on cognitive performance and synaptic plasticity in the hippocampus of 
exposed animals 270-272, but the impact on the offspring has not yet been carefully 
assessed.  
Using the MSUS mouse model, we conducted an unbiased, genome-wide analysis of 
gene expression in the adult hippocampus following postnatal traumatic stress, and 
determined whether gene networks are affected in the offspring of the stressed males. 
Here, we show that the offspring of males exposed to MSUS have widespread alterations 
in gene expression in the hippocampus, specifically in molecular networks implicated in 
synaptic plasticity. Further, the animals have a dramatic shift in functional synaptic 
plasticity, in particular abolished long-term potentiation (LTP) and enhanced long-term 
depression (LTD). This shift is accompanied by impaired hippocampus-dependent long-
term memory. We identify the brain-specific gamma subunit of protein kinase C (Prkcc), a 
gene implicated in synaptic plasticity and memory performance 273,274, as potential 
molecular target. The expression of Prkcc is decreased in the hippocampus of the 
offspring, and DNA methylation is reduced at a specific transcription factor binding site in 
the promoter region both in the brain of the offspring and the sperm of fathers. 
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Results 
To test the effects of early life stress across generations, we subjected newborn mouse 
pups (F1) to MSUS for two weeks, and then bred the males when adult to naïve (non-
stressed) wild-type females to generate F2 progeny. To validate the efficacy of the MSUS 
manipulation, we examined depressive-like behaviors on a forced swim test. Adult F1 
MSUS males and the F2 female offspring spent more time floating than controls (F1: 
controls: 48.3±6.2; MSUS: 71.0±6.6 sec, t(60)=2.5, p=0.015. F2: controls: 46.1±5.6; 
MSUS: 77.2±7.6 sec; t(28)=3.30, p=0.003, Supplementary Figure 1), confirming previous 
findings that MSUS triggers the expression of depressive-like symptoms across 
generations 261-263.  
Once depressive symptoms were confirmed in MSUS animals, we conducted genome-
wide DNA microarrays analysis in adult F2 females at rest (baseline resting condition) to 
determine which molecular pathways are affected by MSUS. In the hippocampus, a brain 
area implicated in depression 275, ANOVA revealed that 156 genes were differentially 
regulated by at least 1.2-fold (data available through GEO, accession number GSE47848) 
in F2 MSUS mice. However, because multiple testing correction (FDR method) proved 
too stringent for the dataset (see Methods), we used a gene set-based approach to 
determine whether gene expression was altered at the network level 276. Gene set 
enrichment analyses (GSEA) identified 49 up-regulated and 30 down-regulated molecular 
pathways in F2 MSUS hippocampus compared to controls (for a complete list, see 
Supplementary Table 1). Notably, the down-regulated pathways contained several 
partially overlapping components critical for excitatory synaptic transmission (i.e. NMDA 
receptor-dependent signaling), neuronal plasticity, and memory formation (Table 1, top).  
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Figure 1. The offspring of MSUS males have altered hippocampal LTP and LTD.  
(A) Hippocampal LTP induced by 1x100Hz stimulation is impaired in F2 MSUS males (n=5 mice) compared 
to controls (n=4 mice). (B) A similar impairment is observed in F2 MSUS females (n=5 mice) compared to 
controls (n=5 mice). (C) LTP induced by 3x100Hz stimulation leads to impaired LTP in F2 MSUS mice (n=6 
mice) compared to controls (n=6 mice). (D) After repeated 3x100Hz stimulation, the LTP impairment 
persists in MSUS mice (n=4 mice) compared to controls (n=6 mice). (E) LTD is enhanced in F2 MSUS mice 
(n=4 mice) compared to controls (n=4 mice). (F) Input-output curves are comparable in F2 MSUS mice (n=6 
mice) and controls (n=6 mice). (G) Paired pulse facilitation is comparable in F2 MSUS mice (n=5 mice) and 
controls (n=6 mice). Thick black bars schematically indicate the LTP/LTD stimulation protocol. Horizontal 
bars indicate the last 20 min of recording used for statistical analyses. Inset traces show a representative 
fEPSP from each group, gray traces represent the average of baseline recording before stimulation, black 
traces show the average over the last 20 min of post-stimulation recording. Data are mean ± s.e.m. 
***=p<0.001, **=p<0.01, *=p<0.05 
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MSUS was previously shown to alter behavioral responses in stressful and aversive 
conditions in adult animals across generations 261-263. Thus, we postulated that 
differences in gene expression between MSUS and control mice may be more 
pronounced in response to a stress challenge. We repeated the DNA microarray analyses 
in F2 animals 45 minutes after exposure to a session of forced swim, an acute form of 
stress that activates gene expression in the hippocampus 277. Using the same statistical 
criteria as above, 1,782 genes with differential expression could be identified in F2 MSUS 
mice after acute stress, representing a 10-fold increase compared to baseline resting 
conditions. GSEA identified 25 gene pathways significantly down-regulated in MSUS 
mice, but no up-regulated pathway (Supplementary Table 1). Notably, the down-regulated 
pathways included NMDA receptor-dependent signaling, synaptic calcium signaling and 
synaptic plasticity networks, which are similar to those identified in resting conditions 
(Table 1). Overall, these results show that plasticity-related gene networks are 
compromised in the offspring of MSUS mice, both at rest and after stress. 
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Brain plasticity pathways down-regulated in F2 MSUS mice - Baseline resting condition 
Rank Gene set name Size NES Nom. p-val 
FDR 
q-val 
5 Reelin signaling pathway – NCI / Nature pathway 28 -1.799 0.0009 0.1130 
6 Unblocking of NMDA receptor glutamate binding and activation 
– Reactome pathway 
15 -1.745 0.0026 0.2058 
8 Synaptic transmission – Reactome pathway 150 -1.585 0.0012 0.2172 
14 CREB phosphorylation through the activation of CaMKII – 
Reactome pathway  
13 -  1.697 0.0055 0.2318 
17 CREB phosphorylation through the activation of RAS – 
Reactome pathway 
23 -1.547 0.0228 0.2394 
19 Activation of NMDA receptor upon glutamate binding and 
postsynaptic events – Reactome pathway  
33 -1.567 0.0137 0.2395 
20 RAS activation upon Ca2+ influx through NMDA receptor – 
Reactome pathway  
15 -1.673 0.0075 0.2400 
30 Glutamate binding – Activation of AMPA receptors and synaptic 
plasticity – Reactome pathway  
28 -1.677 0.0058 0.2479 
 
Brain plasticity pathways down-regulated in F2 MSUS mice - Acute stress condition 
Rank Gene set name Size NES Nom.  p-val 
FDR 
q-val 
1 DARPP 32 events - Reactome pathway 23 -2.356 0.0000 0.0082 
3 RAS activation upon Ca2+ influx through NMDA receptor – 
Reactome pathway 
14 -2.169 0.0006 0.0278 
4 GABA synthesis, release, reuptake and degradation – Reactome 
pathway 
19 -2.101 0.0000 0.0459 
8 CREB phosphorylation through the activation of CaMKII – 
Reactome pathway 
13 -1.930 0.0036 0.1428 
13 AKT phosphorylates targets in the cytosol – Reactome pathway 13 -1.867 0.0073 0.1556 
20 PI3K-AKT activation – Reactome pathway  36 -1.779 0.0024 0.2050 
21 Transmission across chemical synapses – Reactome pathway 173 -1.769 0.0000 0.2095 
 
Table 1. Pathways identified as down-regulated in the hippocampus of F2 MSUS mice relative to controls 
by GSEA.  
Pathways involved in synaptic plasticity are ranked by false discovery rate (FDR) adjusted p-value. Rank = 
Rank of the pathway in the complete set of down-regulated pathways. Size = Number of genes in each 
pathway. NES = normalized enrichment score. Nom. p-val = Nominal (unadjusted) p value.  
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An alteration of signaling pathways can dramatically affect neuronal and network 
functions. The broad and coordinated molecular changes detected in plasticity-related 
pathways in F2 MSUS mice may therefore have important functional consequences. We 
tested this possibility by examining synaptic plasticity in different brain regions in adult F2 
mice. In hippocampus area CA1, long-term potentiation (LTP) induced by one train of 
100Hz stimulation, a form of synaptic strengthening, was abolished in MSUS slices and 
instead, synaptic depression was induced. This effect persisted through recording and 
was the most pronounced 40-60min after the tetanus in both, males and females (Males: 
controls, 135.3 ± 12.1%; MSUS: 43.05 ± 4.6%; t(7)=7.86, p<0.001. Females: controls, 
126.0 ± 13.6%; MSUS: 65.81 ± 14.4%; t(8)=3.04, p=0.016, Figure 1). Two-pathway 
recordings confirmed that the observed depression in F2 MSUS mice was not due to a 
reduced viability of slices, since a stable response could be induced by basal stimulation 
in a non-tetanized pathway (Supplementary Figure S2). We next examined whether a 
stronger stimulation could elicit LTP in MSUS slices and used three trains of 100Hz 
tetanus, a stimulation known to produce late phase LTP 278. Like 1-train LTP, three-train 
LTP was abolished in F2 MSUS slices compared to control slices (40-60 min post 
tetanus, controls: 153.3 ± 13.4%; MSUS: 98.0 ± 12.7%; t(10)=2.98, p=0.013; Figure 1C), 
even when the stimulation was repeated twice (LTP after 1st tetanus: controls 183 ± 
15.8%; MSUS: 128.3 ± 7.5%, t(8)=2.66; p=0.029. LTP after 2nd tetanus: controls 290.9 ± 
40.79%; MSUS: 134.3 ± 13.4%; t(8)=3.01; p=0.017, Figure 1F). We next examined LTD, 
a form of synaptic weakening induced by low frequency stimulation. In hippocampus area 
CA1, LTD was stronger in F2 MSUS slices than in control slices (controls: 74.9 ± 2.9%; 
MSUS: 63.0 ± 3.7%; t(6)=2.50, p=0.046; Figure 1G). The changes in plasticity in F2 
MSUS hippocampus were not due to any gross alteration in basal synaptic transmission 
since input-output curves were similar in control and MSUS slices (Figure 1D). They were 
	   	  
	   	  	  	  	  
116	  
also not due to any major alteration in neurotransmitter release since paired pulse 
facilitation (PPF), a short-term form of presynaptic plasticity 279, was comparable in control 
and MSUS slices (Figure 1E). We then tested if plasticity was disrupted in other brain 
areas and examined LTP in the lateral amygdala (LA), a part of the limbic system 
implicated in fear memory. Stimulation of the thalamic or cortical pathways in LA 280 
showed that LTP was impaired in both pathways in MSUS slices (thalamic pathway: 
controls: 181.1 ± 15.3%; MSUS: 115.1 ± 19.4%; t(11)=2.61, p=0.024; cortical pathway: 
controls: 205.6 ± 52.9%; MSUS: 110.8 ± 12.7%; t(10)=2.05, p=0.068, Supplementary 
Figure S3). Together, these results indicate a global alteration of synaptic plasticity in 
several brain areas in the F2 offspring, with a shift in plasticity towards synaptic 
depression in the adult hippocampus. 
To determine if the LTP impairment in the offspring was inherited from the fathers, we 
examined LTP in the hippocampus of F1 MSUS males. Three-train LTP was abolished in 
F1 MSUS males (controls: 193.5 ± 16.7%; MSUS: 112.7 ± 13.1%; t(9)=3.87, p=0.004; 
Figure 2A), similarly to that in F2 offspring, suggesting that the LTP defect was 
transmitted from fathers to offspring. We then tested if transmission depends on maternal 
care by conducting cross-fostering. When adult, F2 MSUS pups raised by control dams 
(F2 MSUS-CD) had impaired three-train LTP, while F2 control pups raised by dams 
mated to MSUS males (F2 controls-MD) had normal LTP (MSUS-CD: 117.6 ± 7.2%; 
t(16)=4.31, control-MD: 181.8 ± 12.0%; p<0.001, Figure 2B). These results demonstrate 
that the negative effects of paternal stress on LTP are transmitted to the offspring via a 
route independent of maternal care, likely involving the male germline 261,264. Finally, we 
tested whether the LTP defect could also be transmitted to the F3 offspring and for this, 
bred F2 males to naïve females. Three-train LTP was robust in both controls and MSUS 
F3 mice (controls: 214.7 ± 13.6%; MSUS: 177.3 ± 18.1%; t(11)=1.604, p=0.137, Figure 
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2C), indicating that MSUS affects plasticity in directly exposed mice (F1) and their 
progeny (F2), but not in the following generation (F3).  
Synaptic plasticity in the adult brain is important for memory formation, therefore we 
examined memory performance in the animals. We tested contextual fear memory using 
a paradigm in which a novel context is associated with an aversive stimulus (mild foot-
shock). While baseline freezing was similar in control and MSUS mice from F1, F2 or F3 
generations (Figure 3, left), F1 MSUS mice spent significantly less time freezing than 
controls 24 hours after fear conditioning (t(18)=2.52, p=0.021, Figure 3A).  F2 MSUS 
offspring had a similar lower freezing 24 hours after conditioning (t(22)=2.66, p=0.014, 
Figure 3B). In contrast, freezing was normal in F3 MSUS offspring (t(28)=0.82, p=0.417; 
Figure 3C), suggesting that MSUS impairs contextual fear memory in animals directly 
exposed to MSUS (F1) and their offspring (F2), but not in the following generation (F3).  
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Figure 2. Impaired LTP in MSUS mice across generations.  
(A) LTP impairment is observed in F1 MSUS mice (n=6 mice) compared to controls (n=6 mice). (B) A 
similar LTP impairment is observed in MSUS offspring (F2 generation) raised by control dams after cross-
fostering (MSUS-CD; n=8 mice). Control offspring raised by dams previously mated with MSUS males have 
intact hippocampal LTP (control-MD; n=10 mice). (C) In the F3 generation, LTP can be similarly induced in 
MSUS mice (n=7 mice) and controls (n=6 mice). Horizontal bars indicate the last 20 min of recording used 
for statistical analyses. Inset traces show a typical fEPSP from each group, gray traces represent the 
average of baseline recording before stimulation, black traces show the average over the last 20 min of 
post-stimulation recording. Data are mean ± s.e.m. ***=p<0.001 
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Figure 3. Impaired fear memory in MSUS mice across generations.  
Twenty-four hours after contextual fear conditioning, F1 (A) and F2 (B) MSUS mice spend less time 
freezing than controls (F1: controls, n=10; MSUS, n=13. F2: controls, n=12; MSUS, n=12) but not F3 MSUS 
mice (controls, n=12; MSUS, n=18). Left bars show baseline freezing before delivery of the foot-shock. Data 
are mean ± s.e.m. **=p<0.01, *=p<0.05 
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To examine if MSUS affects other forms of memory, we tested the animals on an object 
recognition task. The animals were trained to memorize several objects in a familiar 
arena, then their memory for the objects was evaluated 2.5 or 24 hours later 281. During 
training, F1 control and MSUS mice explored all objects equally, suggesting similar 
acquisition (data not shown). When tested 2.5 hours later, both groups spent more time 
exploring a novel object than the familiar objects (Controls: t(7)=4.11, p=0.004; MSUS: 
t(12)=3.71, p=0.003; Figure 4A), indicating normal object memory. However, 24 hours 
after training, while control mice spent more time exploring the novel object (t(9)=4.43, 
p=0.002), F2 MSUS mice could not discriminate it from the familiar objects (t(10)=1.60, 
p=0.14, Figure 4B), indicating impaired long-term object memory. Similarly to F1 animals, 
F2 MSUS mice had normal object memory 2.5 hours after training (Controls: t(15)=3.90, 
p=0.003; MSUS: t(13)=3.46, p=0.004; Figure 4C), but impaired memory after 24 hours 
(Controls: t(15)=3.90, p=0.001); MSUS: t(14)=1.65, p=0.12, Figure 4D). Together, these 
data suggest that different forms of long-term memory are impaired by MSUS across 
generations.  
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Figure 4. Impaired object recognition memory in MSUS mice across generations.  
Following 2.5 hrs after training, control mice and MSUS mice spend more time exploring the novel object 
than the familiar objects, both (A) in F1 animals (controls: n=10; MSUS: n=13), and (C) the F2 offspring 
(controls: n=15; MSUS: n=15). Twenty-four hrs after training, control mice spend more time exploring the 
novel object, but MSUS mice do not discriminate between novel and familiar objects, both (B) in F1 animals 
(controls: n=10; MSUS: n=11) and (D) the F2 offspring (controls: n=16; MSUS: n=15). Data are mean ± 
s.e.m. **=p<0.01, *=p<0.05 
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In light of the impaired plasticity in MSUS animals, we next examined potential molecular 
targets in plasticity pathways found to be altered in the DNA microarray analyses. Using 
RT-qPCR, we observed that several genes critical for synaptic plasticity were 
downregulated in the hippocampus of F2 MSUS mice, including protein kinase C gamma 
(Prkcc; t(13)=3.03, p=0.009), NR1 subunit of the NMDA receptor (Grin1; t(13)=2.46; 
p=0.028), metabotropic glutamate receptor 1 (Grm1; t(13)=2.26, p=0.044), 
calcium/calmodulin-dependent protein kinase II alpha (Camk2a; t(13)=1.88, p=0.082) and 
ionotropic glutamate receptor AMPA3 (Gria3; t(13)=1.85, p=0.088) (Figure 5A, left panel). 
Several housekeeping genes including Hprt, Actb and Gapdh were not altered (Figure 5A, 
right panel), suggesting pathway-specific suppression of gene expression. To investigate 
the potential mechanisms underlying the altered Prkcc expression, we examined whether 
DNA methylation, an epigenetic mode of gene regulation previously implicated in the 
expression and transmission of the effects of MSUS 261, is affected. We focused on DNA 
methylation at the Prkcc gene because this neuron-specific isoform of PKC is involved in 
LTP induction and memory processes 273,274. Using bisulfite pyrosequencing, we 
quantified DNA methylation in a proximal promoter region of Prkcc that carries 
transcription factor binding sites sufficient for promoter activity 282,283 (Figure 5B). DNA 
methylation was overall low across CpGs contained in this region, except at CpG 6, an 
Sp1 binding site that can bind the transcriptional repressor and/or activator Sp1 and Sp3 
with equal affinity 284, in control samples. At this site, DNA methylation was significantly 
reduced in F2 MSUS hippocampus compared to controls (t(10)=3.30; p=0.008; Figure 
5C). Likewise, in sperm samples of F1 mice, DNA methylation was low at most CpGs 
except at CpG 6, and like in the hippocampus, it was significantly downregulated at this 
site in MSUS samples (t(12)=2.34, p=0.038, Figure 5D).  
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Figure 5. MSUS alters Prkcc expression and DNA methylation in the Prkcc promoter in F1 sperm and F2 
brain.  
(A) Left: RT-qPCR confirms decreased expression of genes related to synaptic plasticity and memory in the 
hippocampus of F2 MSUS mice (n=8) compared to controls (n=8). Right: No group differences are detected 
for housekeeping genes. (B) Schematic representation of the Prkcc promoter region analyzed by 
pyrosequencing including the transcription start site (+1) and the binding site for CREB, Sp1 and AP2. 
Numbers represent individual CpG sites analyzed for DNA methylation (CpG 1-15). (C) DNA methylation is 
reduced at CpG 6 in the hippocampus of F2 MSUS mice compared to controls (n=6/group). (D) DNA 
methylation is reduced at CpG 6 in sperm of F1 MSUS mice (n=7) compared to controls (n=8).  
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Discussion 
Using a model of chronic and unpredictable traumatic stress in early life in mice, we 
demonstrate for the first time that such stress dramatically alters synaptic plasticity in 
different brain areas and impairs long-term memory in both, the animals directly exposed 
to stress and in their offspring. These defects are associated with changes in several 
molecular pathways involved in plasticity and memory, and with specific components of 
these pathways such as Prkcc. We show that Prkcc expression is altered by traumatic 
stress in the hippocampus of the offspring and that DNA methylation in Prkcc promoter is 
reduced in both the hippocampus of the offspring, and the sperm of fathers.  
Early life stress is known to impair neuronal plasticity and cognitive functions during 
adulthood in rodents and humans 271,285,286, in part through perturbations in glutamatergic 
pathways downstream of NMDA receptors 287-289. However, transgenerational effects on 
synaptic plasticity have not been examined so far. Our findings that several glutamatergic 
signaling networks are altered in the hippocampus of the progeny of MSUS males 
demonstrate that the impact of stress on plasticity pathways is specific and 
transgenerational. Two of the molecular pathways suppressed by MSUS both at rest and 
following acute stress, are “calcium-mediated RAS activation through NMDA receptors”, 
and “CaMKII-dependent CREB phosphorylation” pathways. These pathways are critical 
for the induction and the maintenance of LTP 290-292, and may therefore underlie the shift 
in hippocampal plasticity of the offspring.  Such a shift was previously reported in 
response to acute stress 293-295 or chronic social defeat stress 296, but our data newly 
show that it occurs also in the progeny of animals subjected to stress. It is reminiscent of 
the synaptic modification model of homeostasis that proposes that neuronal networks can 
adapt to repeated strengthening or weakening of synapses 296-299.  
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In turn, it suggests that early life stress may modulate the synaptic range rather than 
causing a mere failure in synaptic strengthening, and may explain why the MSUS 
offspring have a relatively mild memory deficit despite a total absence of LTP. The altered 
expression of plasticity-related genes in MSUS offspring including Prkcc, likely underlies 
these defects. Indeed, knockout mice deficient for Prkcc have a phenotype remarkably 
similar to MSUS mice; they lack LTP 273 and have mild memory impairments 274. 
However, Prkcc is only one of several affected targets in MSUS animals, and the 
phenotype likely results from the combined action of all altered genes. Network-wide 
expression changes were recently reported in the paraventricular nucleus (PVN) and the 
bed nucleus of stria terminalis in the offspring of stressed fathers 300. Together, these data 
suggest that broad transcriptomic changes occur in the offspring of stressed fathers in 
several brain regions and may subserve different functions. 
We have previously described transgenerational impairments in social recognition 
memory following MSUS 263. The current results extend these findings by showing that 
cognitive functions are also affected. Interestingly, while our data show the negative 
impact of early traumatic stress on both plasticity and cognitive functions across 
generations, another study showed that stimulating environmental conditions can 
positively modulate plasticity and cognition 301. If mice were transiently exposed to 
enriched environmental conditions early in life, their offspring had enhanced LTP and 
better contextual fear memory. These effects persisted through cross-fostering. Although 
the effect of enrichment was transmitted by females and not males, this suggests that 
plasticity and memory are sensitive to ancestral experience and can be impaired or 
enhanced in the offspring, depending on the environment encountered by the parents. In 
this context, our study shows that both females and males have altered plasticity, while 
previous studies have reported sex-specific effects in the offspring 261-263,302.  
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These results suggest that MSUS has a global impact in the offspring independent of sex 
programming.  
Paternal effects of environmental factors including stress 261,303,304, endocrine disruptors 
305,306, diet 307,308 and drugs of abuse 309 on the offspring have been documented but the 
mechanisms underlying transmission remain poorly understood. In our model, since the 
transmitting males contribute only their germ cells and are never in contact with the 
offspring 264, transmission most likely implicates epigenetic mechanisms in the germline. 
The altered DNA methylation in MSUS fathers’ sperm i.e. at the Prkcc promoter, provides 
evidence that DNA methylation in germ cells is associated with transmission. This 
complements our previous demonstration of DNA hypo- or hyper-methylation at several 
loci in MSUS sperm and the brain of F2 offspring 261. Such alterations may be maintained 
or relayed by other mechanisms in the developing embryo (which undergoes widespread 
demethylation) and contribute to the adult phenotypes. How DNA methylation is modified 
by early life experiences in sperm cells, and how changes are targeted to specific loci 
remain unknown. Although male germ cells are the primary career, maternal care may 
also contribute to the transmission of paternal effects since females can adjust their level 
of care depending on the fitness and attractiveness of their mate 310,311. This possibility is 
however excluded for the MSUS model since the impairments (LTP) persist after cross-
fostering. Interestingly, while emotional reactivity, depressive-like behaviors and social 
behaviors due to MSUS are transmitted down to the F3 generation 261,263, the LTP and 
memory impairments are transmitted only to F2 and do not affect F3 animals (Figures 2 
and 3). This suggests that different mechanisms may be recruited for transmission, some 
that persist across multiple generations and some that are more transient 264,312.  More 
work is however needed to identify these different mechanisms.  
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The present findings in mice are expected to have important consequences in humans, 
since cognitive ability and intelligence, although known to be highly heritable traits 313, still 
have no clear genetic basis 314,315. Such “missing heritability” of complex traits is 
classically postulated to be due to gene-gene and gene-environment interactions 
involving multiple, often rare gene variants that bring small effects 316. Our results suggest 
that environmental factors encountered by parents also contribute to the heritability of 
cognitive abilities. Such a link is difficult to study in humans due to the complexity of the 
genome 312. Animal models like ours therefore provide a valuable means to study the 
underlying mechanisms, and gain novel insight with potential implication for the clinic.   
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Supplementary Figures 
 
 
Figure S1. MSUS fathers and their offspring express depressive-like symptoms.  
F1 MSUS males (A) and the female offspring (B) spend more time floating than controls. Data are mean ± 
s.e.m. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Two-pathway recordings in hippocampus of F2 mice.  
Hippocampal LTP induced by 1x100Hz stimulation is impaired in F2 MSUS mice compared to controls 
(controls: 129.2 ± 10.3%; MSUS: 60.55 ± 12.9%; t(10)=4.16, p=0.002). Recordings from the second, non-
stimulated pathway demonstrate a stable fEPSP response throughout recording (MSUS: n=6 mice; 
Controls: n=6 mice). Data are mean ± s.e.m. **=p<0.01 controls tetanized versus MSUS tetanized. 
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Figure S3. The offspring of MSUS males have impaired LTP in the amygdala.  
(A) LTP induced at the thalamic pathway is impaired in F2 MSUS mice (n=7 mice) compared to controls 
(n=6 mice). (B) LTP induced at the cortical pathway is slightly impaired in F2 MSUS mice (n=7 mice) 
compared to controls (n=5 mice). Thick black horizontal bars indicate tetanus stimulation. Narrow horizontal 
bars indicate the last 20 min of recording used for statistical analyses. Bar graphs represent the fEPSP 
slope averaged across the last 20 min of recording. Data are mean ± s.e.m. *=p<0.05, #=p<0.07  
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Supplementary Tables 
Table  S1 
MSUS VERSUS CONTROLS – DOWN-REGULATED PATHWAYS – ACUTE STRESS CONDITION  
 
Rank Gene Set Name SIZE ES NES NOM p-val 
FDR 
q-val 
1 DARPP 32 events - Reactome Pathway 23 -0.6528 -2.356298 0.000000 0.008157 
2 Cytosolic tRNA aminoacylation – Reactome Pathway 24 -0.6278 -2.291540 0.000000 0.009718 
3 RAS activation upon Ca2+ influx through NMDA receptor – Reactome Pathway 14 -0.6892 -2.168596 0.000623 0.027765 
4 GABA synthesis, release, reuptake and degradation – Reactome Pathway 19 -0.6157 -2.101296 0.000000 0.045921 
5 ARF1 Pathway - NCI / Nature Pathway 18 -0.6040 -2.048614 0.001346 0.068716 
6 Glycolysis – Reactome 25 -0.5301 -1.984103 0.000000 0.110520 
7 Circadian repression of expression by REV-ERBA – Reactome Pathway 21 -0.5537 -1.955585 0.000673 0.128240 
8 CREB phosphorylation through the activation of CaMKII – Reactome Pathway 13 -0.6316 -1.930020 0.003578 0.142792 
9 RORA activates circadian expression – Reactome Pathway 22 -0.5321 -1.899508 0.003353 0.169132 
10 Attachment of GPI anchor to UPAR – Reactome Pathway 6 -0.8054 -1.889692 0.003676 0.167082 
11 Beta-catenin phosphorylation cascade – Reactome Pathway 15 -0.5928 -1.885943 0.004531 0.156791 
12 Trafficking and processing of endosomal TLR – Reactome Pathway 10 -0.6662 -1.877965 0.006150 0.153535 
13 AKT phosphorylates targets in the cytosol – Reactome Pathway 13 -0.6115 -1.866960 0.007304 0.155606 
14 N-Cadherin signaling events – NCI / Nature Pathway 29 -0.4845 -1.865257 0.001498 0.146645 
15 Gluconeogenesis – Reactome Pathway 27 -0.4826 -1.829601 0.002187 0.183170 
16 Formation of tubulin folding intermediates by CCT-TRIC – Reactome Pathway 15 -0.5618 -1.801884 0.008497 0.214504 
17 Circadian clock – Reactome Pathway 47 -0.4123 -1.795617 0.001786 0.211789 
18 Glucose metabolism – Reactome Pathway 56 -0.3991 -1.795491 0.000000 0.200196 
19 Purine ribonucleoside monophosphate biosynthesis – Reactome Pathway 10 -0.6448 -1.794888 0.012479 0.190483 
20 PI3K-AKT activation – Reactome Pathway 36 -0.4370 -1.778563 0.002423 0.205005 
21 Transmission across chemical synapses – Reactome Pathway 173 -0.3230 -1.768603 0.000000 0.209498 
22 Folding of actin by CCT-TRIC – Reactome Pathway 8 -0.6699 -1.760188 0.018395 0.213463 
23 Prefoldin-mediated transfer of substrate to CCT-TRIC – Reactome Pathway 19 -0.4988 -1.738467 0.011392 0.238631 
24 mRNA splicing – Reactome Pathway 94 -0.3450 -1.738288 0.000000 0.229013 
25 mRNA splicing – major pathway – Reactome Pathway 94 -0.3450 -1.724625 0.002445 0.242496 
 
 
 
   
 
 
	   	  
	   	  	  	  	  
135	  
MSUS VERSUS CONTROLS – DOWN-REGULATED PATHWAYS – BASELINE RESTING CONDITION 
       
  Rank Gene Set Name SIZE ES NES NOM p-val FDR q-val 
1 Interaction between L1 and ankyrins – Reactome Pathway 24 -0.7557 -2.257383 0.000000 0.000000 
2 L1CAM interactions – Reactome Pathway 89 -0.5084 -1.912260 0.000000 0.046290 
3 CDO in myogenesis – Reactome Pathway 29 -0.5958 -1.846442 0.000128 0.068890 
4 Myogenesis – Reactome Pathway 29 -0.5958 -1.859348 0.000514 0.074750 
5 Reelin signaling pathway – NCI / Nature Pathway 28 -0.5834 -1.799209 0.000896 0.113026 
6 Unblocking of NMDA receptor – glutamate binding and activation – Reactome Pathway 15 -0.6548 -1.744675 0.002632 0.205848 
7 Axon guidance – Reactome Pathway 248 -0.4165 -1.722747 0.000000 0.206658 
8 Synaptic transmission – Reactome Pathway 150 -0.3990 -1.584540 0.001167 0.217212 
9 Other semaphorin interactions – Reactome Pathway 12 -0.6344 -1.585063 0.017888 0.221986 
10 Stabilization and expansion of the E-cadherin adherens junction – NCI / Nature Pathways 62 -0.4440 -1.587115 0.005237 0.223520 
11 ARF6 downstream pathway – NCI / Nature Pathway 82 -0.4627 -1.726816 0.000449 0.223844 
12 E-Cadherin signaling in the nascent adherens junction – NCI / Nature Pathway 62 -0.4440 -1.587543 0.006009 0.228887 
13 Dopamine neurotransmitter release cycle – Reactome Pathway 14 -0.6483 -1.705752 0.006517 0.228903 
14 CREB phosphorylation through the activation of CaMKII – Reactome Pathway 13 -0.6593 -1.696555 0.005491 0.231816 
15 Neurofascin interactions – Reactome Pathway 7 -0.7347 -1.587609 0.015335 0.235469 
16 Interactions of the immunoglobulin superfamily – IgSF-member proteins – Reactome Pathway 33 -0.4908 -1.564844 0.015705 0.239350 
17 CREB phosphorylation through the activation of RAS – Reactome Pathway 23 -0.5227 -1.546832 0.022805 0.239404 
18 Serotonin neurotransmitter release cycle – Reactome Pathway 12 -0.6147 -1.548960 0.027837 0.239528 
19 Activation of NMDA receptor upon glutamate binding and postsynaptic events – Reactome Pathway 33 -0.4926 -1.567301 0.013687 0.239533 
20 RAS activation upon Ca2+ influx through NMDA receptor – Reactome Pathway 15 -0.6274 -1.672524 0.007497 0.240002 
21 Alk2 signaling events – NCI / Nature Pathway 7 -0.7389 -1.588293 0.015715 0.240818 
22 LKB1 signaling events – NCI / Nature Pathway 300 -0.3739 -1.561564 0.000101 0.241294 
23 PDGFR-beta signaling pathway – NCI / Nature Pathway 38 -0.4768 -1.571220 0.011886 0.242319 
24 cGMP effects – Reactome Pathway 19 -0.5501 -1.549473 0.024148 0.243350 
25 Transport of inorganic cations/anions and aminoacids/oligopeptides – Reactome Pathway 88 -0.4174 -1.567619 0.002785 0.244797 
26 EphrinB-EPHB pathway – NCI / Nature Pathway 40 -0.4810 -1.589420 0.009510 0.245537 
27 CDC42_signaling events – NCI / Nature Pathway 199 -0.3814 -1.554728 0.000515 0.246470 
28 Inactivation of CDC42 and RAC – Reactome Pathway 9 -0.7161 -1.663413 0.007069 0.247612 
29 Attachment of GPI anchor to uPAR – Reactome Pathway 6 -0.7554 -1.549746 0.018757 0.247895 
30 Glutamate binding and activation of AMPA receptors and synaptic plasticity – Reactome Pathway 28 -0.5434 -1.676505 0.005809 0.247935 
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MSUS VERSUS CONTROLS – UP-REGULATED PATHWAYS – BASELINE RESTING CONDITION  
         
   Rank Gene Set Name SIZE ES NES NOM p-val FDR q-val 
1 Respiratory electron transport – Reactome Pathway 63 0.6370 2.946389 0.000000 0.000000 
2 
Respiratory electron transport, ATP synthesis by 
chemiosmotic coupling, and heat production by uncoupling 
proteins – Reactome Pathway 
78 0.5879 2.792768 0.000000 0.000000 
3 Influenza viral RNA transcription and replication – Reactome Pathway 92 0.4548 2.233631 0.000000 0.005975 
4 mRNA splicing – minor pathway – Reactome Pathway 42 0.5081 2.155038 0.000553 0.014429 
5 Viral mRNA synthesis – Reactome Pathway 14 0.6923 2.126668 0.001428 0.016374 
6 Viral mRNA translation – Reactome Pathway 76 0.4426 2.100230 0.000000 0.018371 
7 Eukaryotic translation termination – Reactome Pathway 76 0.4262 2.050785 0.000000 0.027008 
8 Formation of a pool of free 40s subunits – Reactome Pathway 86 0.4137 2.019702 0.000000 0.033370 
9 Peptide chain elongation – Reactome Pathway 76 0.4172 1.998227 0.000000 0.037169 
10 Eukaryotic translation elongation – Reactome Pathway 79 0.4052 1.940087 0.000000 0.060635 
11 Peptide ligand binding receptors – Reactome Pathway 153 0.3557 1.909695 0.000000 0.075031 
12 Eukaryotic translation initiation – Reactome Pathway 103 0.3670 1.862322 0.000000 0.099083 
13 CAP dependent translation initiation – Reactome Pathway 103 0.3670 1.869817 0.000000 0.100039 
14 RNA polymerase I promoter opening – Reactome Pathway 22 0.5233 1.837691 0.004062 0.106987 
15 RNA polymerase III transcription initiation from type 3 promoter – Reactome Pathway 22 0.5093 1.822229 0.001686 0.107281 
16 GTP hydrolysis and joining of the 60s ribosomal subunit – Reactome Pathway 96 0.3615 1.808095 0.000000 0.108174 
17 3'UTR mediated translational regulation – Reactome Pathway 96 0.3645 1.828253 0.000000 0.108592 
18 Intrinsic pathway – Reactome Pathway 13 0.5939 1.800778 0.009240 0.109269 
19 Regulation of gene expression in beta cells – Reactome Pathway 93 0.3686 1.810373 0.000000 0.112304 
20 Pausing and recovery of TAT mediated HIV 1 elongation – Reactome Pathway 29 0.4571 1.773288 0.004634 0.113769 
21 mRNA capping – Reactome Pathway 28 0.4864 1.837865 0.003699 0.114385 
22 Tachykinin receptors bind tachykinins – Reactome Pathway  5 0.8127 1.782317 0.008907 0.115320 
23 Abortive elongation of HIV 1 transcript in the absence of TAT – Reactome Pathway 23 0.4967 1.786875 0.006650 0.116555 
24 RNA Pol II CTD phosphorylation and interaction with CE – Reactome Pathway 26 0.4756 1.775288 0.006203 0.116822 
25 Translation – Reactome Pathway 110 0.3463 1.763380 0.000000 0.118204 
26 TAT mediated HIV 1 elongation arrest and recovery – Reactome Pathway 29 0.4571 1.745147 0.007480 0.130885 
27 Influenza infection – Reactome Pathway 133 0.3291 1.719972 0.000000 0.152703 
28 Glyoxylate metabolism – Reactome Pathway 4 0.8569 1.710628 0.008262 0.157669 
29 Dual incision reaction in TC-NER – Reactome Pathway 28 0.4414 1.661481 0.010914 0.189147 
30 Thyroxine biosynthesis – Reactome Pathway 5 0.7604 1.663282 0.028348 0.192601 
31 Regulatory RNA pathways – Reactome Pathway 21 0.4712 1.653687 0.017666 0.193690 
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32 Influenza life cycle – Reactome Pathway 128 0.3225 1.675252 0.000000 0.196160 
33 MicroRNA (miRNA) biogenesis – Reactome Pathway 21 0.4712 1.663841 0.012955 0.198098 
34 Formation of transcription-coupled NER (TC-NER) repair complex – Reactome Pathway 28 0.4414 1.666733 0.011829 0.200764 
35 RNA polymerase III chain elongation – Reactome Pathway 12 0.5554 1.629703 0.037248 0.202798 
36 HIV 1 elongation arrest and recovery – Reactome Pathway 30 0.4200 1.630219 0.011854 0.207538 
37 RNA polymerase III transcription initiation – Reactome Pathway 28 0.4266 1.620798 0.010658 0.209204 
38 Pausing and recovery of HIV 1 elongation – Reactome Pathway 30 0.4200 1.630645 0.013315 0.212688 
39 Elongation arrest and recovery – Reactome Pathway 30 0.4200 1.634678 0.017729 0.213119 
40 Pausing and recovery of elongation – Reactome Pathway 30 0.4200 1.613256 0.009307 0.214012 
41 Regulation of beta-cell development – Reactome Pathway 105 0.3159 1.591330 0.000000 0.222677 
42 Formation of HIV 1 elongation complex containing HIV 1 TAT – Reactome Pathway 40 0.3808 1.583066 0.010352 0.223899 
43 
Regulation of insulin-like growth factor (IGF) activity by 
insulin-like growth factor binding proteins (IGFBPS) – 
Reactome Pathway 
16 0.4893 1.592934 0.031826 0.225693 
44 Pyrimidine salvage reactions – Reactome Pathway 7 0.6452 1.585097 0.050695 0.226014 
45 HIV 1 transcription elongation – Reactome Pathway 40 0.3808 1.594623 0.008830 0.228727 
46 TAT mediated elongation of the HIV 1 transcript – Reactome Pathway 40 0.3808 1.598296 0.010281 0.229238 
47 Integration of provirus – Reactome Pathway 7 0.6318 1.561780 0.054626 0.243970 
48 ID pathway – Cancer Cell Map 10 0.5669 1.558317 0.054372 0.244015 
49 Phosphorylation of EMI1 – Reactome Pathway 5 0.7184 1.561835 0.056467 0.249080 
 
 
 
Table  S2 
RT-qPCR primers 
GENE Forward Primer Reverse Primer 
Prkcc 
Grin1 
TGTGGCCATCTGCAAAGGGTTC 
TGTGTCCCTGTCCATACTCAAGTC 
ACCTCTCCCAATCGATCCAACG 
CCGAACCCATGTCTTATCCAGGTC 
Grm1 AGTGCCTTCACCACCTCTGATG ATTCTGGCTGCCTCTTCTTGGC 
Camk2a TGAGGACGAAGACACCAAAGTGC CTTCGATCAGCTGCTCTGTCAC 
Gria3 ACGGGCAGAGTCCAAACGCA CGTGTCATGCCCGACACCAA 
Tubd1 
Hprt 
Actb 
TCTCTTGCTAACTTGGTGGTCCTC 
GTTGGGCTTACCTCACTGCTTTC 
TGTTACCAACTGGGACGACA 
GCTGGGTCTTTAAATCCCTCTACG 
CCTGGTTCATCATCGCTAATCACG 
TTTGAGACCTTCAACACCCC 
Gapdh CAGCAATGCATCCTGCACC TGGACTGTGGTCATGAGCCC 
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MATERIALS AND METHODS  
Animals 
C57Bl/6J females and males (2.5 months) were obtained from Janvier (France) and 
maintained in a temperature- and humidity-controlled facility on a 12-hour reversed light–
dark cycle with food and water ad libitum. All procedures were carried out in accordance 
to Swiss cantonal regulations for animal experimentation. 
Unpredictable maternal separation combined with maternal stress (MSUS) and 
breeding paradigm 
MSUS was conducted as previously described 261. Briefly, first generation (F1) pups were 
separated from their mothers for 3 hrs per day at unpredictable times from postnatal day 
1 to 14. During separation, mothers were randomly exposed to restraint stress (20 min) or 
forced swim stress (5 min). At postnatal day 21, pups were weaned and placed in 
standard cages (3-5 mice per cage, each from a different litter to avoid litter effects). 
When adult, males subjected to MSUS and controls (F1) were bred to naïve wild-type 
females to produce an F2 generation. At least 10 males were used for breeding in each 
group. F2 mice were reared in normal conditions not involving any stress (3-5 mice per 
cage, each from a different litter to avoid litter effects). To generate F3 offspring, F2 males 
were paired to naïve females as described for the F2 breeding. 
Cross-fostering design 
When F2 mice were born, 3 litters per group were pseudo-randomly (matched for litter 
size and birthdate) selected for cross-fostering. These litters where removed from their 
mother within 48 hrs after birth and immediately placed with a foster-mother from the 
opposite experimental group (MSUS vs. control). Donor and recipient dams were 
removed from their cage and placed in separate, clean holding cages. The litter to be 
fostered was picked up and placed in the recipient’s homecage and gently mixed with the 
dirty bedding to transfer the recipient’s scent 317. Then the recipient dam was returned to 
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the cage and the pups were henceforth raised under normal facility and rearing 
conditions. Maternal care was determined by daily visual inspection. 
Gene expression analyses 
F2 female mice (MSUS and controls) were sacrificed by cervical dislocation either 45 min 
(acute stress condition) or 2 weeks (baseline resting condition) after exposure to forced 
swim stress (6 min, 18°C water) (conducted as two independent experiments in 
independent breeding cohorts of mice). The brain was removed and the hippocampus 
rapidly dissected on ice and stored at -80°C until further processing. RNA was extracted 
with RNeasy spin columns (Qiagen) and amplified using the Ovation RNA amplification kit 
V2 (Nugen Technologies). RNA was labeled, hybridized and analyzed using NimbleGen 
Mouse Gene Expression 12x135K Arrays according to manufacturer’s recommendations. 
Independent experiments were conducted for baseline resting condition and for acute 
stress condition. Each RNA sample (6 samples per group for baseline resting condition, 
and 8 samples per group for acute stress condition) was hybridized to two different 
NimbleGen slides, providing a technical replicate for each measurement.  
Quality control and statistical analysis of microarray data 
Principal Component Analysis (PCA) demonstrated high reproducibility between technical 
replicates in both experiments and identified one low quality replicate in baseline resting 
conditions that was removed from further analyses (the second technical replicate was 
not affected). After scanning, data were processed with RMA (Robust Multichip Average) 
318 according to NimbleGen’s recommendation. For analysis of differential expression, the 
expression matrix was log2 transformed and imported into Partek Genomics Studio 
(Partek Inc, Missouri, USA) and Limma 319.  
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To identify probes for genes that are differentially expressed in both groups, a linear 
model was run. Multiple testing corrected p-values (FDR method) were calculated for the 
contrast between groups in both experiments.  
Gene set enrichment analyses (GSEA) 
GSEA algorithm implemented in the GSEA tool from Broad Institute 320 was used to 
detect coordinated changes in gene expression in biological networks. This gene-set 
based approach is particularly powerful for datasets where overall expression analysis 
proves insensitive 276. T-statistic values (on a gene level) from the ANOVA model 
described above were used as a measure of change for all genes whose mouse gene ID 
could be mapped to a human ortholog, based on the Roche genome annotation 
infrastructure. As a gene set library, we used the Pathway Commons 321 collection, 
limiting down to the pathways that contain between 5 to 500 genes. Significantly 
regulated pathways were identified within GSEA by performing random permutations in 
the gene space, the number of permutations set to 10000. The lists of significantly up- or 
down-regulated pathways were sorted by FDR corrected p-values, set to the 
recommended 25% threshold 320. 
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) 
RT-qPCR was performed using SYBR green (Roche) on a Light-Cycler II 480 (Roche) 
according to manufacturer’s recommendations and normalized against Tubulin delta 1 
(Tubd1). Cycling conditions were 5 min at 95°C, then 45 cycles with denaturation (10 sec 
at 95°C), annealing (10 sec at 60°C), and elongation (10 sec at 72°C). Primers were 
designed using Primer3Plus 322 or Quantprime 323 (see Supplementary Table 2) and 
tested for quality and specificity by melt-curve analysis, gel electrophoresis and 
appropriate negative controls. 
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Bisulfite pyrosequencing 
Genomic DNA was extracted and purified using DNeasy Blood and Tissue Kit (Qiagen), 
and bisulfite treated (EZ DNA Methylation Gold Kit, Zymo Research) according to 
manufacturer’s recommendations. PCR and pyrosequencing primers were designed 
using Pyromark Assay Design 2.0 (Qiagen). Amplicons containing the Prkcc promoter 
region were generated using a standard PCR protocol, an unmodified forward primer 
(AAGATGATTGATTGATTGGGAGAA), and a biotin-labeled reverse primer  
(ACACCTAACCATACACAACACAC). Subsequent pyrosequencing on the PCR amplicon 
was performed using a PyroMark Q24 Advanced pyrosequencer and appropriate 
reagents (Pyromark Advanced CpG Reagents, Qiagen) following manufacturer’s 
recommendations. For high-resolution sequencing, the following two sequencing primers 
were used (sequencing primer1: AAGGGGGTGGATAAG; sequencing primer2: 
GGGGGTTTTAAATTGAAAT). Average methylation levels of CpG sites were quantified 
using PyroMark Q24 2.0 software (Qiagen).  
Electrophysiology 
Adult F2 female and male mice were used for electrophysiological experiments. Mice 
were anesthetized with isoflurane and rapidly decapitated. Heads were immediately 
immersed in ice-cold freshly prepared artificial CSF (aCSF: 119 mM NaCl, 2.5 mM KCl, 
26 mM NaHCO3, 1.3 mM NaH2PO4, 2.5 mM CaCl2, 1.3 mM MgCl2, 11 mM C6H12O6) 
before brain extraction. aCSF was gassed with 95% O2 and 5% CO2. The hippocampus 
was isolated and sagittal slices (400 µm) were prepared with a LEICA VT 1000S 
vibratome. Slices were allowed to recover at 34°C for at least one hour, then placed in an 
interface chamber at room temperature and perfused with aCSF. Extracellular fEPSPs 
were recorded with a glass microelectrode (2-5 MΩ filled with aCSF) positioned in the 
stratum radiatum of area CA1.  
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A concentric bipolar stimulating electrode was used to elicit fEPSPs by stimulation of 
Schaffer collateral fibers. Basal synaptic transmission was assessed by stimulating 
Schaffer collaterals with increasing stimulation intensity (I/O curves). Stimulation intensity 
was adjusted to elicit fEPSP amplitudes that were around 50% of maximum size. LTP 
was induced by applying either a single 1-sec train (100 Hz at test strength) or three 1-
sec trains (100 Hz, test strength) 20 sec apart. LTD was induced with 1200 pulses at 2Hz 
for 10 minutes, repeated three times at 10 min intervals 324. Paired-pulse facilitation (PPF) 
was induced with two stimulations delivered at an intertrial interval (ITI) of 50, 100, 150, 
200, 300, or 400 ms, and was determined as the ratio of fEPSP slope evoked by the 
second pulse to fEPSP slope evoked by the first pulse (EPSP2/EPSP1). For amygdala 
recordings, horizontal slices were prepared and the recording electrode was placed in the 
lateral nucleus of the amygdala. To stimulate fibers originating from the thalamus 
(thalamic pathway), one stimulation electrode was placed close to the internal capsule, 
while another stimulation electrode was placed externally to the capsule to stimulate 
fibers from the auditory cortex (cortical pathway) 280. LTP was induced with one 1-sec 
train at 100 Hz (at test strength). Signals were amplified with an Axopatch 200B amplifier 
(Molecular Devices, Union City, CA) digitized by a Digidata 1322A interface (Axon 
Instruments, Molecular Devices, US) and sampled at 10 kHz. Recordings were acquired 
using Labview (National Instruments) and analyzed with Clampfit (Molecular Devices). 
Experimenters were blind to treatment for all experiments. One or more slices from each 
mouse were used and data were averaged, so that animals and not slices were 
considered biological replicates.  
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Behavioral testing  
Behavior testing was conducted in adult (3-8 month-old) male mice to avoid confounding 
effects of estrous cycle. Testing was carried out under dim red light and animals were 
monitored by direct observation and/or videotracking.  
Each animal was tested on a maximum of three tasks, 1 to 2 weeks apart, starting with 
the least aversive task. An experimenter blind to the treatment conditions conducted all 
tests and analyses. 
Forced swim test. Mice were placed in a plastic cylinder (18 cm high, 13 cm diameter) 
filled with 18 ± 1°C water up to 12 cm height for 6 min. Time floating was manually scored 
and the last 4 min were used to compare performance in the different groups 325. 
Novel object recognition. Mice were habituated to an arena (grey plastic box, 25x25x20 
cm) in a dimly lit room for 10 min on 3 consecutive days. They were then allowed to 
explore three identical unfamiliar objects in the arena for 10 min. After 2.5 hrs, they were 
placed back in the arena but one of the objects was replaced with a novel object. Using 
the same animals, this test was then repeated using different objects and a 24-hr delay to 
test long-term memory. The arena floor was lit with infrared light and animals were 
tracked with an infrared camera and tracking system (Viewpoint, France). Time spent 
exploring each object was recorded normally.  
Contextual fear conditioning. Mice were exposed to a novel context for 3 min in an 
automated fear conditioning system (TSE, Germany), then received two 1 sec 0.6 mA 
foot-shocks 1 min apart. Movement was detected by infrared beams in the testing 
chamber (TSE, Germany). Freezing, defined as the absence of any detectable movement 
for >1 sec, was measured for 4 min in the same context immediately before and 24 hrs 
after fear conditioning and served as an indicator of memory.  
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Statistical analyses 
For RT-qPCR and pyrosequencing analyses, independent samples t-tests were used to 
compare both groups. For electrophysiology, independent samples t-tests were used to 
compare the fEPSP slope over the last 20 min of LTP/LTD recordings between groups. 
For object recognition memory, ANOVA was used with object as within-subjects factor.  
Significant main effects were further analyzed using paired-samples t-tests to compare 
the average time spent exploring the familiar objects and time spent exploring the novel 
object. Fear conditioning data were analyzed using independent samples t-tests. Values 
were considered outliers if they deviated > 2 SDs from the group mean, and this outlier 
exclusion criterion was pre-established.  
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